PCN22 ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS (Englisch)
- Neue Suche nach: Rana, C.
- Neue Suche nach: Mann, K.
- Neue Suche nach: Wadhwa, A.
- Neue Suche nach: Rana, C.
- Neue Suche nach: Mann, K.
- Neue Suche nach: Wadhwa, A.
In:
VALUE IN HEALTH
;
14
, 3
;
A158
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PCN22 ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS
-
Beteiligte:
-
Erschienen in:VALUE IN HEALTH ; 14, 3 ; A158
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A158
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A1
-
CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTINGBonafede, R. P. / Pearson, D. / Babich, J. / Chastek, B. / Becker, L. / Watson, C. / Chaudhari, S. / Harrison, D. J. / Gandra, S. R. et al. | 2011
- A4
-
SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS: ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHINGMcCarrier, K. P. / Durkin, M. B. / Dirani, R. / Markowitz, M. / Slabaugh, S. L. / Martin, M. L. et al. | 2011
- A5
-
CE4 USING DYNAMIC TRANSMISSION MODELS TO ESTIMATE THE COST EFFECTIVENESS OF VACCINES: FOUR DIFFERENT METHODS AND THEIR RELEVANCE FOR DECISION MAKERSMauskopf, J. / Talbird, S. E. / Standaert, B. et al. | 2011
- A8
-
MC3 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIASAn, J. J. / Nichol, M. B. et al. | 2011
- A9
-
EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORTMcAdam Marx, C. / Ye, X. / Bouchard, J. / Aagren, M. / Conner, C. / Brixner, D. et al. | 2011
- A12
-
PHP4 WHEN STAKEHOLDERS DON'T AGREE: DISCREPANCIES IN MAB “APPROVALS” OVER THE PAST TEN YEARSMiller, K. L. / Stevens, C. A. et al. | 2011
- A13
-
PHP10 THE TEMPORAL ASSOCIATION BETWEEN PRESCRIBED OPIOIDS AND THE NATIONAL DEATH RATE DUE TO OPIOID POISONINGGokhale, M. N. / Martin, B. et al. | 2011
- A15
-
PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGSSepulveda, B. / Doyle, J. / White, C. et al. | 2011
- A16
-
PHP28 COMPLIANCE WITH TREATMENT GUIDELINE RECOMMENDATIONS: USE OF OVER-THE-COUNTER MEDICATIONS IN PATIENTS RECEIVING BISPHOSPHONATES, ANTIEPILEPTICS, OR CHRONIC OPIOIDSBarnes, K. D. / Heaton, P. C. et al. | 2011
- A17
-
PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT: THE GOOD, THE BAD, AND THE FUTUREMachado, M. / Fonseca, E. / Fonseca, M. et al. | 2011
- A18
-
PHP41 THE CHANGING LANDSCAPE OF ORPHAN DRUG PROVISION IN THE EU5 AND THE UNITED STATESMcConkey, D. et al. | 2011
- A20
-
PHP52 INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008Liu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. et al. | 2011
- A22
-
PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEMMauskopf, J. / Chirila, C. / Masaquel, C. / Boye, K. S. / Bowman, L. / Birt, J. / Grainger, D. et al. | 2011
- A23
-
PHP69 HOW MUCH FOR A QALY IN KOREAKim, Y. / Shin, S. / Park, S. / Song, H. / Park, J. / Bae, E. / Ahn, J. et al. | 2011
- A24
-
PHP74 CLINICAL TRIAL LEARNING CURVES AFFECT OUTCOMES MEASUREMENT, PATIENT SAFETY AND TRIAL SUCCESS: CONTRIBUTING FACTORS AND A POTENTIAL SOLUTION IN CLINICAL TRIAL SIMULATIONSpinner, D. S. / Walter, J. W. / Vazquez-Gragg, M. / Bloise, T. / Stafford-Smith, M. / Faulkner, E. C. / Taekman, J. M. et al. | 2011
- A25
-
PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTSSura, S. D. / Chabria, A. / Sansgiry, S. et al. | 2011
- A27
-
PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATESShah, A. J. / Patil, D. S. / Kadakia, A. / Aparasu, R. R. et al. | 2011
- A28
-
PHP95 EXPECTED CHANGES IN HEALTH CARE UTILIZATION DUE TO PATIENT PROTECTION AND AFFORDABLE CARE ACTGhushchyan, V. H. / Sullivan, P. W. / Naim, A. / Nair, K. V. et al. | 2011
- A30
-
PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS: INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'SSchwartz, E. L. / Davis, E. A. / Belazi, D. / Hasan, S. et al. | 2011
- A31
-
PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME: A CRITICAL REVIEWChristley, Y. / Duffy, T. / Martin, C. R. et al. | 2011
- A34
-
PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDYBhounsule, P. / Abughosh, S. et al. | 2011
- A37
-
PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPhatak, H. / Pan, X. / Kawabata, H. et al. | 2011
- A38
-
PCV36 EVALUATION OF THE HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH TOLVAPTAN USAGE AMONG HEART FAILURE PATIENTS WITH HYPONATREMIA FROM THE EVEREST TRIALDasta, J. F. / Chiong, J. R. / Kim, S. / Lin, J. et al. | 2011
- A39
-
PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTIONRao, S. / Lin, F. J. / Ojo, O. / Patel, V. / Yu, S. / Zhan, L. / Touchette, D. R. et al. | 2011
- A40
-
PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZILPepe, C. / Machado, M. / Olimpio, A. / Canella, M. / Ramos, R. et al. | 2011
- A42
-
PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTIONPan, X. / Kawabata, H. / Phatak, H. et al. | 2011
- A43
-
PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATIONYan, X. / Shaya, F. T. et al. | 2011
- A45
-
PCV74 ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTANAtif, M. / Asif, M. / Saleem, F. / Ahmad, N. / Saqib, N. et al. | 2011
- A46
-
PCV79 IMPACT OF DISEASE MANAGEMENT PROGRAM “DE TODO CORAZON” OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIAPaz, J. J. / Granados, C. E. / Morales, C. / Rodriguez, N. / Buitrago, L. A. / Guete, A. / Caceres, H. A. / Ramirez, P. / Pardo, R. et al. | 2011
- A47
-
PCV84 EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CAREMartinez Valverde, S. / Reyes Morales, H. / Castro Rios, A. / Perez Cuevas, R. / Klunder Klunder, M. / Salinas Escudero, G. et al. | 2011
- A48
-
PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASEZhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
- A49
-
PCV95 USING COMPUTERIZED PHYSICIAN ORDER ENTRY OF ANTI-HYPERTENSIVE MEDICATIONS TO CONNECT INDICATIONS WITH PRESCRIBING AND IMPROVE PROBLEM LIST DOCUMENTATIONGalanter, W. / Walton, S. / Falck, S. / Rosencranz, H. / Adimadhyam, S. et al. | 2011
- A50
-
PCV100 HEALTH CARE UTILIZATION AND COSTS FOR A MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMPinto, S. L. / Partha, G. et al. | 2011
- A52
-
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUESGandhi, P. K. / Ried, L. D. / Huang, I. C. / Kimberlin, C. / Kauf, T. / Suh, D. C. et al. | 2011
- A53
-
PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDRENBerbari, J. / Reynolds, S. / Heil-Ruess, M. / Iskedjian, M. et al. | 2011
- A56
-
PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASISMamolo, C. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. et al. | 2011
- A57
-
PSS25 MEDICATION ADHERENCE TO TOPICAL MEDICATIONS AND HEALTHCARE EXPENDITURES IN MEDICAID-ENROLLED CHILD WITH ATOPIC DERMATITISOu, H. T. / Feldman, S. R. / Balkrishnan, R. et al. | 2011
- A58
-
PSS30 BURDEN OF INFANTILE HEMANGIOMA: DEVELOPMENT OF A QUESTIONNAIRETaieb, C. / Voisard, J. J. / Ruiz, F. et al. | 2011
- A59
-
PSY6 TRANSFUSIONAL IRON OVERLOAD (TIO) MONITORING AND TREATMENT: FINDINGS FROM AN ELECTRONIC MEDICAL RECORDS REVIEW STUDY AT THE MOFFITT CANCER CENTER AND RESEARCH INSTITUTEDuh, M. S. / Wetzstein, G. / Guo, A. / Sasane, M. / Sarda, S. P. / Korves, C. / Wang, S. T. / Wei, R. / Clinton, B. / Ray, L. et al. | 2011
- A60
-
PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME: THE PATIENTS' PERSPECTIVESLee, S. S. / Kim, S. H. / Kim, S. K. / Lee, C. K. / Lee, H. S. / Lee, S. H. / Park, Y. B. / Ko, S. K. / Park, H. J. et al. | 2011
- A61
-
PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY: A BMI TRAJECTORY-BASED MODELWang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Wong, E. / Flum, D. / Arterburn, D. / Sullivan, S. D. et al. | 2011
- A62
-
PSY21 COST-EFFECTIVENESS ANALISYS OF TREATMENT WITH AMFEPRAMONE (DIETHYLPROPION) IN OBESITY IN MEXICORamirez Ramirez, M. / Soto-Molina, H. / Rizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. et al. | 2011
- A63
-
PSY26 IMPACT OF HYPONATREMIA ON PATIENT OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN HOSPITALIZED PATIENTSDeitelzweig, S. / Amin, A. / Lin, J. / Belk, K. / Baumer, D. / Lowe, T. et al. | 2011
- A64
-
PSY31 HEMOPHILIA A: PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASEStrandberg-Larsen, M. / Gater, A. / Thomson, A. et al. | 2011
- A65
-
PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Jolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. et al. | 2011
- A66
-
PSY42 EPIDEMIOLOGY AND QALITY OF LIFE OF ANEMIC PATIENTS ON DIALYSIS IN RUSSIA: PATIENT-REPORTED DATAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. / Eliseeva, E. / Baev, V. / Vezikova, N. et al. | 2011
- A67
-
PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING: RESULTS FROM THE POWER TRIALAlavi, R. / Appel, L. / Brancati, F. / Clark, J. / Mohr, P. / Daumit, G. et al. | 2011
- A69
-
PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATESPatel, J. G. / Shah, A. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. et al. | 2011
- A70
-
PSY64 GE CENTRICITY® ELECTRONIC MEDICAL RECORDS STUDY: COMORBIDITIES AND BIOLOGIC EXPERIENCE AMONG PATIENTS RECEIVING GOLIMUMABTandon, N. / Carter, C. / Haas, S. / Gunnarsson, C. et al. | 2011
- A71
-
PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)Ma, Q. / Kauf, T. / Hall, A. G. et al. | 2011
- A72
-
PSY75 PREVALENCE RATIOS AGAINST ODDS RATIOS AS EFFECT MEASURES IN A CROSS-SECTIONAL STUDY OF OBESITY AND ITS CHRONIC COMORBID CONDITIONSPatel, J. G. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. et al. | 2011
- A73
-
PSY80 PRIORITIZATION AND WEIGHTING OF PATIENT-RELEVANT ENDPOINTS (PRES) AS PART OF THE IQWIGS EFFICIENCY FRONTIER METHOD IN GERMANYMü / hlbacher, A. / Bridges, J. F. / Bethge, S. / Dintsios, C. M. / Schwalm, A. / Nü / bling, M. et al. | 2011
- A74
-
PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)Yarger, S. / Nwokeji, E. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. et al. | 2011
- A76
-
PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CAREGanz, M. / Clemens, J. Q. / Anger, J. / Denevich, S. / Shah, D. / Carlson, A. / Wittek, M. R. / Pashos, C. et al. | 2011
- A77
-
PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZILCarvalho, D. D. / Garcia, V. / Abbud-Filho, M. / Nishikawa, A. M. / Asano, E. / Nita, M. E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. et al. | 2011
- A78
-
PUK24 USE OF BIOMARKERS IN PROPENSITY SCORE MATCHING TO MITIGATE CHANNELING BIAS IN A RETROSPECTIVE COHORT OF ESRD PATIENTSWilson, S. M. / Rubin, J. L. et al. | 2011
- A79
-
PMD5 OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDYLee, V. / Yan, B. / Chan, T. / Woo, A. / Lee, K. K. / Yu, C. M. et al. | 2011
- A80
-
PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATESPollock, R. F. / Curtis, B. / Boye, K. S. / Timlin, L. / Valentine, W. J. et al. | 2011
- A81
-
PMD16 COMPARISON OF COST AND CLINICAL OUTCOMES OF OPEN VERSUS LAPAROSCOPIC THORACIC PROCEDURES IN THE UNITED STATESHashemi, L. / Minshall, M. E. et al. | 2011
- A82
-
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?Parthan, A. / Pruttivarasin, N. / Taylor, D. / Davies, D. / Yang, G. / Pawar, V. / Weinstein, M. et al. | 2011
- A86
-
PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUESDavid, G. / Gunnarsson, C. / Moore, M. / Howington, J. / Miller, D. / Maddaus, M. / McKenna, R. / Meyers, B. / Swanson, S. et al. | 2011
- A87
-
PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALESKontekakis, A. / Gaiser, S. et al. | 2011
- A88
-
PSU14 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS ON KIDNEY TRANSPLANT WAITING LIST - WHAT FACTORS REALLY MATTER?Ong, S. C. / Chow, W. L. / van der Erf, S. / Joshi, V. D. / Tee, P. S. / Lu, Y. M. / Kee, T. Y. et al. | 2011
- A89
-
PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?Choi, J. E. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Lee, N. R. / Joo, C. K. et al. | 2011
- A91
-
PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL: SIMULATIONS PERFORMED USING ARCHESZgibor, J. C. / Kuo, S. / Schuetz, C. A. / Roberts, M. S. / Cohen, M. D. et al. | 2011
- A92
-
PDB11 COMPARISON OF MULTIVARIABLE-ADJUSTED LOGISTIC REGRESSION WITH PROPENSITY SCORE-MATCHED, PROPENSITY SCORE-STRATIFIED, AND PROPENSITY SCORE-ADJUSTED LOGISTIC REGRESSION MODELSKhoza, S. / Barner, J. C. / Richards, K. et al. | 2011
- A94
-
PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISONTilling, C. / Owens, D. / Keech, M. et al. | 2011
- A96
-
PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADAHaig, J. / Lawrence, D. / Barbeau, M. / Blouin, J. / Cruess, A. et al. | 2011
- A97
-
PDB37 MAIL-ORDER PHARMACY USE AND MEDICATION ADHERENCE AMONG MEDICARE PART D BENEFICIARIES WITH DIABETESZhang, L. / Zakharyan, A. / Stockl, K. M. / Harada, A. S. / Curtis, B. S. / Solow, B. K. et al. | 2011
- A98
-
PDB43 TREATMENT COMPLIANCE TO DIABETES CARE: A CROSS-SECTIONAL STUDY FROM PAKISTANParveen, M. / Piyarali, S. et al. | 2011
- A99
-
PDB48 DO WE KNOW WHAT ARE THEY TRADING OFF? – A FEASIBILITY STUDY TO MEASURE QUALITY OF LIFE IN TAIWANESE TYPE-2 DIABETES OUTPATIENTS BY TIME-TRADE-OFF METHODHuang, L. H. / Chen, L. C. / Huang, Y. B. / Hwang, S. J. et al. | 2011
- A100
-
PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIARaval, A. D. / Dhanaraj, E. / Bhansali, A. et al. | 2011
- A101
-
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCETriki, N. / Greenberg, D. / Mossinson, D. / Shani, S. et al. | 2011
- A102
-
PDB64 EVALUATION OF THE BURDEN OF ILLNESS OF TYPE-2 DIABETES MELLITUS IN A MEDICARE POPULATIONCostantino, M. E. / Song, F. / Stacy, J. N. / Aagren, M. / Bouchard, J. / Marrett, E. et al. | 2011
- A103
-
PDB69 EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANYMiller, L. A. / Burudpakdee, C. / Zagar, A. / Bhosle, M. / Reaney, M. / Schabert, V. F. et al. | 2011
- A105
-
PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS: EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTINGRicher, E. / Dourdin, N. / Goetghebeur, M. et al. | 2011
- A108
-
PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCESalinas Escudero, G. / Martinez Valverde, S. / Villasis Keever, M. A. / Garduñ / o Espinosa, J. / Reyes Ló / pez, A. / Muñ / oz Herná / ndez, O. et al. | 2011
- A111
-
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONSAjmera, M. R. / Wilkins, T. L. / Sambamoorthi, U. et al. | 2011
- A112
-
PIH42 A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR HAEMOPHILIA INHIBITOR PATIENTSWeatherall, J. / Mesterton, J. / Lindgren, P. / Dalen, J. et al. | 2011
- A113
-
PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)Ali, A. K. et al. | 2011
- A114
-
PIN6 TRENDS OF HEPATITIS A INCIDENCE FROM 2005 TO 2008Eisenberg, D. / Changolkar, A. K. / Misurski, D. A. et al. | 2011
- A116
-
PIN17 TREATMENT PATTERNS AND DRUG TREATMENT COSTS ASSOCIATED WITH NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)-BASED ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE HIV-1 INFECTED PATIENTSDiels, J. / Langham, S. / Nuyts, G. / Adriaenssen, I. et al. | 2011
- A117
-
PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR (ATV+RTV) COMPARED WITH LOPINAVIR/RITONAVIR (LPV+RTV) IN TREATMENT-NAÏVE HIV-INFECTED PATIENTS IN MEXICO: A MODEL BASED ON THE CASTLE STUDYJuarez-Garcia, A. / Martinez-Rivera, G. / Donato, B. M. et al. | 2011
- A118
-
PIN29 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS WITH FAILURE TO VANCOMYCIN THERAPY IN MEXICOBriones, B. / Martinez Revelles, M. / Garcí / a-Contreras, F. et al. | 2011
- A119
-
PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSISTarride, J. E. / Burke, N. / von Keyserlingk, C. / O'Reilly, D. / Xie, F. / Goeree, R. et al. | 2011
- A120
-
PIN39 IMMUNIZATION BARRIERS AND SUGGESTED SOLUTIONS IN IRAQAl-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. et al. | 2011
- A121
-
PIN45 IMPACT OF GOVERNMENT SPONSORED POLIO CONTROL PROGRAM ON KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO IN GENERAL COMMUNITY OF BAHAWALPUR, PAKISTANAtif, M. / Asif, M. / Sulaiman, A. / Saleem, F. / Ahmad, N. / Saqib, N. / Qamar, M. et al. | 2011
- A122
-
PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIESHedden, E. / Jessop, A. / Field, R. I. et al. | 2011
- A123
-
PMS4 THE ASSOCIATION BETWEEN TERIPARATIDE PERSISTENCE AND FRACTURE OUTCOMES IN A US CLAIMS DATABASEYu, S. / Foster, S. / Burge, R. / Anderson, J. / Gelwicks, S. / Meadows, E. et al. | 2011
- A125
-
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASEPark, S. J. / Lee, E. K. et al. | 2011
- A126
-
PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSISAlfonso-Cristancho, R. / Serra, N. / Aiello, E. C. / Roa, C. N. et al. | 2011
- A127
-
PMS26 COST-EFFECTIVENESS MODELING IN OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND OVERVIEWSmolen, H. J. / Myers, J. A. / Smolen, L. J. et al. | 2011
- A128
-
PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAINvan der Velde, G. / Hincapié / C. / Schieir, O. / Coté / P. / Hogg-Johnson, S. / Paulden, M. / Krahn, M. et al. | 2011
- A129
-
PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITISKirson, N. / Rao, S. / Birnbaum, H. G. / Kantor, E. / Wei, R. / Cifaldi, M. et al. | 2011
- A130
-
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDYGagol, G. / Fernandez, N. / Rouanet, S. et al. | 2011
- A131
-
PMS47 EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONEHan, C. / Gathany, T. / Tandon, N. / Hsia, E. et al. | 2011
- A136
-
PRS1 SEVERE ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING BETA AGONISTS AMONG CHILDREN AND ADOLESCENTS WITH ASTHMAGuo, J. J. / Tsai, K. / Kelton, C. / Bian, B. / Wigle, P. et al. | 2011
- A138
-
PRS12 A NATIONAL SURVEY OF SOCIETAL COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SOUTH KOREAKim, J. / Park, S. / Kim, Y. / Lee, E. / Oh, Y. / Boo, Y. et al. | 2011
- A139
-
PRS17 COST EFFECTIVENESS OF TOP 20 HIGHEST SELLING DRUGSAggarwal, S. et al. | 2011
- A140
-
PRS22 COPD MAINTENANCE MEDICATION ADHERENCE: INFLUENCE ON HOSPITALIZATION AND SPENDING IN A MEDICARE POPULATIONSimoni-Wastila, L. / Wei, Y. J. / Qian, J. / Zuckerman, I. H. / Stuart, B. / Shaffer, T. / Dalal, A. / Bryant-Comstock, L. et al. | 2011
- A143
-
PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONSVaidya, V. / Peeters, M. / Partha, G. / Potnis, P. et al. | 2011
- A144
-
PRS43 REGRESSION VERSUS PROPENSITY MATCHING AS OUTCOME ANALYSIS ADJUSTMENT METHODS: EXAMPLE USING COPD INITIAL THERAPIESRoberts, M. / Dalal, A. A. et al. | 2011
- A145
-
PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES: A TUTORIALBaser, O. et al. | 2011
- A146
-
PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANYGissel, C. / Goetz, G. / Repp, H. et al. | 2011
- A147
-
PRM13 COMPARISON OF DISCRETE EVENTS SIMULATION SOFTWARE FOR USE IN HEALTH ECONOMICS & OUTCOMES RESEARCHAnaya, P. et al. | 2011
- A148
-
PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECTSullivan, P. W. / Ghushchyan, V. H. et al. | 2011
- A150
-
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSISPerampaladas, K. / Doble, B. M. / Xie, F. et al. | 2011
- A152
-
PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)Griffin, A. / Wild, D. / Morisky, D. E. et al. | 2011
- A154
-
PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDYHawkins, R. / Wagstaff, J. / Nathan, P. / Sarda, S. P. / Vekeman, F. / Korves, C. / Dasgupta, S. / O'Mara, S. / Fitton, S. / Hayers, J. et al. | 2011
- A158
-
PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGSGarg, V. / Raisch, D. W. / Mckoy, J. / Trifilio, S. / Holbrook, J. / Samaras, A. T. / West, D. et al. | 2011
- A159
-
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVELuporsi, E. / Mahi, L. / Moore, C. / Wernli, J. / Bugat, R. et al. | 2011
- A160
-
PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSISGriffiths, R. I. / Gleeson, M. L. / Mikhael, J. R. / Danese, M. D. et al. | 2011
- A161
-
PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)Alemayehu, B. / Parry, D. / Engel-Nitz, N. M. / Kulakodlu, M. / Nathan, F. et al. | 2011
- A162
-
PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATESTang, D. / Alberts, D. S. / Nevins, R. / Sullivan, S. / Skrepnek, G. H. et al. | 2011
- A164
-
PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?Djalalov, S. / Beca, J. / Hoch, J. et al. | 2011
- A166
-
PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIATaylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. et al. | 2011
- A167
-
PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLICGatialova, K. / Bellova, K. / Petrova, L. / Majtas, J. / Binder, R. et al. | 2011
- A168
-
PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UPFunke, V. A. / Moellmann-Coelho, A. / Asano, E. / Nita, M. E. / Donato, B. M. / Rahal, E. et al. | 2011
- A169
-
PCN84 PATIENTS' PREFERENCES FOR THE TREATMENT OF COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT (DCE) SURVEYAlbassam, A. / Noyce, P. / Ashcroft, D. et al. | 2011
- A170
-
PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALSPeeters, P. / Casamayor, M. / Moï / se, P. / Holmstrom, S. et al. | 2011
- A172
-
PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTSLe, T. K. / Winfree, K. B. / Yang, H. / Marynchenko, M. / Yu, A. P. / Frois, C. / Wu, E. Q. et al. | 2011
- A173
-
PCN106 RESEARCH ON THE FACTORS AFFECTING THE ADOPTION OF HIGH VALUE MEDICAL CONSUMES IN LESS DEVELOPED AREAS OF CHINAJing, W. / Guanglian, X. et al. | 2011
- A176
-
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASELepisto, E. M. / Vandergrift, J. L. / Kalemkerian, G. P. / Pisters, K. M. / Zornosa, C. / Rabin, M. S. / Reid, M. E. / Koczywas, M. / Otterson, G. A. / Ettinger, D. S. et al. | 2011
- A177
-
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CAREHeron, L. / De Castro Carpeñ / o, J. / Chouaid, C. / Vergnenè / gre, A. / Bischoff, H. G. / Walzer, S. et al. | 2011
- A178
-
PCN131 REPRESENTING UNCERTAINTY IN CALIBRATED CANCER TREATMENT MODELS: A PRACTICAL APPROACHTaylor, D. C. / Leahy, K. J. / Weinstein, M. et al. | 2011
- A179
-
PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES: EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCHGorman, K. / Miller, R. / McGarvey, N. / Corey-Lisle, P. et al. | 2011
- A180
-
PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATIONWagner, J. S. / Goren, A. et al. | 2011
- A181
-
PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENTBrook, R. A. / Kleinman, N. L. / Smeeding, J. et al. | 2011
- A183
-
PGI20 IBS-C PATIENT SYMPTOM REPORTS: ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONSCarson, R. T. / Lewis, B. E. / Shiff, S. J. / Johnston, J. M. / Dennee-Sommers, B. / Lasch, K. E. / Hwang, S. / Marquis, P. et al. | 2011
- A185
-
PMH3 RISK OF HIP FRACTURES IN ELDERLY MEDICARE BENEFICIARIES USING ATYPICAL OR TYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE ANALYSISDharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. et al. | 2011
- A186
-
PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTSAparasu, R. R. / Mehta, S. / Chen, H. et al. | 2011
- A187
-
PMH14 CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPYJarosz, J. / Miernik, K. / Wachal, M. / Walczak, J. et al. | 2011
- A188
-
PMH19 THE BUDGET IMPACT ANALYSIS OF NALTREXONE IN THE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS IN POLANDWalczak, J. / Semeniuk, A. / Pacocha, K. / Nogas, G. et al. | 2011
- A189
-
PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCYBaser, O. / Wang, L. / Xie, L. et al. | 2011
- A190
-
PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTSDesai, P. / Lawson, K. / Barner, J. C. / Rascati, K. L. et al. | 2011
- A191
-
PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIAPark, H. / Kim, D. N. / Rascati, K. L. et al. | 2011
- A192
-
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPYSvedsater, H. / Locklear, J. / Johal, S. / Stillman, I. O. et al. | 2011
- A193
-
PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIAKim, D. N. / Park, H. / Rascati, K. L. et al. | 2011
- A194
-
PMH50 A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIAOsborne, R. H. / Dalton, A. / Hertel, J. / Schrover, R. / Kingsford Smith, D. et al. | 2011
- A195
-
PMH55 THE BURDEN OF DIAGNOSED DEPRESSION AND SLEEP DIFFICULTIES ON QUALITY OF LIFE, WORK PRODUCTIVITY, AND RESOURCE USEGupta, S. / Goren, A. / Gabriel, S. / Kim, E. / Dupclay, L. et al. | 2011
- A199
-
PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAMLavigne, J. E. / King, D. A. / Lu, N. / Knox, K. L. / Kemp, J. E. et al. | 2011
- A200
-
PMH81 RELATIONSHIP BETWEEN ADHERENCE TO ANTIDEPRESSANT TREATMENTS AND DEPRESSIVE RELAPSEJung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. et al. | 2011
- A201
-
PND1 PRESCRIBING PATTERNS OF DRUGS HAVING ANTICHOLINERGIC ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASEGala, S. D. / Gupte, K. P. / Wu, W. K. et al. | 2011
- A202
-
PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATATang, J. / Levin, M. C. / Bailey, J. E. / Faris, R. J. / Hong, S. H. / Chang, C. F. / Wang, J. et al. | 2011
- A203
-
PND11 THE ECONOMIC BURDEN OF OSA IN EACH OF THE METABOLIC SYNDROME COMPONENTS LEVELSGreenberg-Dotan, S. / Yan, X. / Scharf, S. M. / Shaya, F. T. et al. | 2011
- A206
-
PND27 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN THE UNITED STATESBenhaddi, H. / Helmers, S. et al. | 2011
- A207
-
PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLANDBloudek, L. M. / Hansen, R. N. / Liu, L. / Batty, A. J. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. et al. | 2011
- A208
-
PND38 THE HIDDEN TOLL OF CAREGIVER BURDEN IN MULTIPLE SCLEROSISStewart, M. / Phillips, A. / Edwards, N. / Gupta, S. / Goren, A. et al. | 2011
- A209
-
PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSYde la Loge, C. / Dimova, S. / Massagli, M. / Wicks, P. et al. | 2011
- A210
-
PND48 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN CHRONIC NEUROMUSCULAR DISORDERBanks, P. / Martin, C. R. / Petty, R. et al. | 2011
- A211
-
PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTSBoklage, S. / Preblick, R. / Yaldo, A. / Golick, M. / Pocoski, J. et al. | 2011
- A212
-
PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEMTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Moretti, A. I. / Santos, P. M. / Tolentino, A. C. et al. | 2011
- A213
-
PND64 APPLICATION OF PREDICTIVE MODELING TO CLASSIFY FREQUENT SNORING IDENTIFIED FROM ROUTINE MEDICAL EXAMINATIONS USING THE NHANES DATABASERow, B. et al. | 2011
- A215
-
ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations| 2011
- A223
-
ISPOR 16TH Annual International Meeting Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
-
EE2 VALIDATION OF THE UPDATED CHARLSON COMORBIDITY INDEX (CCI) TO PREDICT HEALTH CARE UTILIZATION FOR DIABETIC PATIENTS USING ADMINISTRATIVE DATACheng, L. I. / Rascati, K. L. / Trice, S. / Lawson, K. / Barner, J. C. et al. | 2011
-
EV4 MORE BANG FOR YOUR BUCK: TAKE A RISK WHEN ANALYSING INTERVIEW DATARoberts, G. et al. | 2011
-
PHP13 THE IMPACT OF A QUALITY IMPROVEMENT INITIATIVE ON INAPPROPRIATE MEDICATION USE IN THE OUTPATIENT ELDERLYDudash, K. / Templin, M. / Keith, S. W. / Del Canale, S. / Maio, V. et al. | 2011
-
PHP20 MEDICATION USE SURVEY OF INPATIENTS WITH BASIC MEDICAL INSURANCE (2010)Xiong, X. et al. | 2011
-
PHP30 CAN PRICING SCHEMES IMPROVE MARKET ACCESS FOR INNOVATIVE HIGH PRICED DRUGS?Anastasaki, E. / Colasante, W. / Imbeah-Ampiah, R. et al. | 2011
-
PHP83 HTA DECISION DRIVERS FOR ACCEPTANCE OF HIGH ICER SUBMISSIONS AND REJECTION OF LOW ICER SUBMISSIONSTernouth, A. M. / Jakel, A. / Plested, M. / Modha, R. et al. | 2011
-
PHP94 THE ROLE OF HEALTH-RELATED QUALITY OF LIFE DATA IN THE DRUG APPROVAL PROCESSES IN THE UNITED STATES AND EUROPE: A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS FROM 2006 TO 2010Marquis, P. / Caron, M. / Emery, M. P. / Scott, J. / Acquadro, C. et al. | 2011
-
PHP108 THE CASE OF RARE DISEASE DRUGS BEFORE AND AFTER THE INTRODUCTION OF PRICING BODIES: LESSONS LEARNED FROM BRAZIL AND CANADA, IMPLICATIONS FOR THE UNITED STATESCost, P. / Snyder, T. / Zaidi, Q. et al. | 2011
-
PHP109 AN OUTCOMES PROFILE REGISTRY FOR ESTABLISHING A BASELINE MATRIX IN COMPARATIVE EFFECTIVENESS STUDIES IN PREDICTIVE PHARMACOLOGYWheeler, C. et al. | 2011
-
PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATIONLaMori, J. C. / Gross, H. J. / Patel, A. A. / Crain, M. / DiBonaventura, M. D. / Mody, S. H. / Schein, J. et al. | 2011
-
PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODELSchuetz, C. A. / van Herick, A. / Alperin, P. / Peskin, B. / Hsia, J. / Gandhi, S. K. et al. | 2011
-
PCV30 A META-ANALYSIS OF RISK FACTORS TO DEVELOP CARDIOVASCULAR EVENTS AND STROKE IN SUBJECTS EXPOSED TO ENVIROMENTAL TOBACCO SMOKEVillasis-Keever, M. / Rendó / n-Macias, M. / Escamilla_Nuñ / ez, A. / Mould-Quevedo, J. F. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PCV38 POTENTIAL ECONOMIC IMPACT OF DYSPNEA ASSOCIATED WITH TICAGRELOR USEBonafede, M. / Jing, Y. / Gdovin Bergeson, J. / Liffmann, D. K. / Makenbaeva, D. / Graham, J. P. / Deitelzweig, S. et al. | 2011
-
PCV39 CHARACTERIZATION OF COSTS ASSOCIATED WITH STROKE REHABILITATION: A REVIEW OF THE LITERATURESacco, P. / Johnson, J. / Verma, A. et al. | 2011
-
PCV46 LONG-TERM COSTS AND HEALTH OUTCOMES OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR BASED ON THE EU LABEL - COST-EFFECTIVENESS ANALYSIS BASED ON THE PLATO STUDYHenriksson, M. / Nikolic, E. / Janzon, M. / Hauch, O. / Levin, L. x. / Wallentin, L. et al. | 2011
-
PCV56 COST-MINIMIZATION ANALYSIS OF LANDIOLOL FOR CT SCANNING FOR CVD SUSPICIOUS PATIENTS IN JAPANIgarashi, A. / Fujito, K. / Fukuda, T. et al. | 2011
-
PCV66 ADHERENCE RATES AMONG HEALTH PLAN MEMBERS STARTING GENERIC VERSUS BRAND STATIN THERAPYChen, Q. / Kachur, S. G. / Fatodu, H. / Garber, H. et al. | 2011
-
PCV91 BETA BLOCKERS AND DIURETICS USAGE IN CROATIA AND SLOVENIA DURING A NINE-YEAR PERIODVitezic, D. / Kucan, M. / Vitezic, M. / Kovacevic, M. / Mrsic Pelcic, J. et al. | 2011
-
PCV94 ANTICOAGULANT USE, THE PREVALENCE OF BRIDGING AND RELATION TO LENGTH OF STAY AMONG HOSPITALIZED PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONSmoyer-Tomic, K. / Sander, S. / Siu, K. / Smith, D. M. / Amin, A. / Johnson, B. H. et al. | 2011
-
PCV104 REAL-WORLD SIDE EFFECT DATA ON CHOLESTEROL MEDICATIONS – OUTPUTS FROM AN ONLINE PATIENT COMMUNITYCascade, E. / Plummer, R. C. / Mangini, N. S. et al. | 2011
-
PCV108 CARDIOVERSION TREATMENT PATTERNS AND OUTCOMES AMONG ACUTE ATRIAL FIBRILLATION PATIENTS IN 5 EUROPEAN COUNTRIESBuono, J. L. / Russell, T. / Worsfold, A. / Bash, L. D. et al. | 2011
-
PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSIONKowalski, J. / Yeh, W. S. / O'Leary, B. / Ackerman, S. / Sharma, S. / Adena, M. et al. | 2011
-
PSS17 THE EFFECT OF ORAL CP-690,550 ON PRURITUS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASISMamolo, C. M. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. et al. | 2011
-
PSS22 SYSTEMATIC REVIEW OF THE QUALITY OF LIFE LITERATURE IN CHILDREN WITH ATOPIC DERMATITISIskedjian, M. / Navarro, V. / Khondoker, F. / Farah, B. et al. | 2011
-
PSS27 EFFECT OF TREATMENT SWITCH ON THE COST-EFFECTIVENESS OF BIOLOGICS IN PSORIASIS IN PERU AND COLOMBIAAlandete, J. C. et al. | 2011
-
PSS29 DEVELOPMENT OF THE MODIFIED OCULAR COMFORT INDEX (MOCI)Johnson, M. E. / Ruiz, W. M. / Li, J. Z. et al. | 2011
-
PSY1 SEVERE RENAL, HEPATIC AND GASTROINTESTINAL EVENTS ASSOCIATED WITH DEFERASIROX IN PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIAHuang, W. F. / Hsiao, F. Y. / Chou, H. C. / Tsai, Y. W. / Yen, H. C. / Ke, W. M. et al. | 2011
-
PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIASchelfhout, J. / Kauf, T. et al. | 2011
-
PSY33 EXPLORING THE FACTOR STRUCTURE OF THE PROMIS FATIGUE ITEM BANK IN PATIENTS WITH FIBROMYALGIASchilling, S. / Blum, S. I. / Tourkodimitris, S. / Williams, D. A. et al. | 2011
-
PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)Tarride, J. E. / Harrington, K. / Balfour, R. / Simpson, P. / Foord, L. / Anderson, L. / Lakey, W. K. et al. | 2011
-
PSY61 CHARACTERISTICS OF GOLIMUMAB UTILIZATION AND COSTS IN A SPECIALTY PHARMACY PROVIDER (SPP) SETTINGEllis, L. / Tandon, N. / Mody, S. / Doshi, D. / Baek, C. / Gunnarsson, C. et al. | 2011
-
PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNSSchmeichel-Mueller, C. / Buysman, E. / Bolge, S. / Ingham, M. / McKenzie, R. S. et al. | 2011
-
PSY71 HEALTH AND FUNCTIONAL STATUS FOR INDIVIDUALS WITH THROMBOCYTOPENIA IN THE UNITED STATES: EVIDENCE FROM NHANESKauf, T. / Schelfhout, J. / Nelson, D. R. / Wang, P. F. et al. | 2011
-
PSY78 ESTIMATING THE BMI-MORTALITY RELATION USING FRACTIONAL POLYNOMIALSWong, E. / Wang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Flum, D. / Arterburn, D. / Sullivan, S. D. et al. | 2011
-
PMD38 META ANALYSIS OF THE IMPACT OF HEALTH INFORMATION TECHNOLOGY ON MEDICATION SAFETY IN HOSPITALS: AN INTERRUPTED TIME SERIES STUDYChang, J. / Patel, I. / Kim, B. / Kwon, I. / Balkrishnan, R. et al. | 2011
-
PMD39 MINI-HTA TRENDS FOR MEDICAL DEVICES IN THE NORDICSGrundstrom, J. P. / Friberg, S. / Medin, E. et al. | 2011
-
PSU3 LONG-TERM CLINICAL EFFECTIVENESS AND STABILITY OF LASIK AND SURFACE ABLATION IN KOREA: A SYSTEMATIC REVIEW APPROACHLee, N. R. / Choi, J. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Joo, C. K. et al. | 2011
-
PSU8 PATTERNS OF ACUTE CLOPIDOGREL USE AND INPATIENT COSTS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTINGJohnston, S. S. / Bell, K. / Gdovin Bergeson, J. / McMorrow, D. / Graham, J. et al. | 2011
-
PSU17 EXCESS PAYMENTS FROM MEDICARE FOR INPATIENT SURGERYBaser, O. et al. | 2011
-
PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDYTilling, C. / Vora, J. / Keech, M. et al. | 2011
-
PDB38 A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIALBuysman, E. / Conner, C. / Liu, F. / Aagren, M. / Bouchard, J. et al. | 2011
-
PDB71 CHARACTERISTICS OF EARLY ADOPTERS OF EXPENSIVE MEDICATIONSJuarez, D. T. / Davis, J. / Fujimoto, R. / Chung, R. S. et al. | 2011
-
PIH3 COMPARISON OF IN VITRO FERTILIZATION TRENDS AMONG INSURED PATIENTS IN MANAGED CARE IN THE UNITED STATES; COMPARISON OF STATES WITH AND WITHOUT MANDATED COMPREHENSIVE FERTILITY COVERAGEFincher, C. / Kozma, C. / Hubbard, J. / Meletiche, D. M. / Velez, F. F. et al. | 2011
-
PIH16 COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICORamí / rez-Ramí / rez, M. A. / Peniche-Otero, G. / Mould-Quevedo, J. F. / Nuñ / o-Langre, C. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PIH22 PRIMARY MEDICATION NONADHERENCE: A RETROSPECTIVE ANALYSIS OF ELECTRONIC PRESCRIPTIONS IN AN INTEGRATED HEALTHCARE SETTINGShin, J. / Cheetham, C. T. / Sanchez, R. J. / Deminski, M. C. / Udall, M. / Vansomphone, S. S. / McCombs, J. et al. | 2011
-
PIH46 SPECIAL PRECAUTIONS TO CONSIDER WHEN PERFORMING COGNITIVE DEBRIEFING OF SENSITIVE TOPICSGawlicki, M. / Handa, M. / McKown, S. et al. | 2011
-
PIN15 ECONOMIC BURDEN OF SURGICAL SITE INFECTIONS IN HIP AND KNEE ARTHROPLASTY - A COST-OF-ILLNESS-STUDY FOR GERMANYHanstein, T. J. / Gaiser, G. et al. | 2011
-
PIN33 COST-UTILITY ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAïVE PATIENTS IN SWEDENChaudhary, M. / Elbasha, E. H. / Kumar, R. N. / Lundberg, J. et al. | 2011
-
PIN40 DO PATIENTS AND PHYSICIANS HAVE SIMILAR PREFERENCES FOR HEALTH CARE DECISIONS INVOLVING UNCERTAIN OUTCOMES FOR CHRONIC HEPATITIS B IN GERMANY AND TURKEY?Lescrauwaet, B. / Mohamed, A. F. / Johnson, F. R. / Hauber, A. B. et al. | 2011
-
PMS13 OSTEOPOROSIS-RELATED FRACTURE COSTS AMONG FEMALE COMMERCIALLY INSURED AND MEDICARE PATIENTSBonafede, M. / Shi, N. / Viswanathan, H. N. / Yurgin, N. et al. | 2011
-
PMS63 SATISFACTION, PREFERENCE AND REASONS FOR BIOLOGIC TREATMENT DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITISTandon, N. / Bolge, S. / Annunziata, K. et al. | 2011
-
PRS8 DISEASE PROGRESSION IN CYSTIC FIBROSIS — SYNTHESIS OF SURVIVAL EVIDENCEBecker, C. C. / Vieira, M. C. / Harrow, B. / Liou, T. G. / Jansen, J. P. et al. | 2011
-
PRS23 NON-ADHERENCE IN ISONIAZID TREATED PATIENTS AS MEASURED BY THE TEMPTATION TO SKIP THERAPY (TEST) SCALEDeshpande, C. / Scimeca, S. / Carter, J. / Willey, C. et al. | 2011
-
PRS24 IMPACT OF MORBIDITY, PSYCHOLOGICAL DISTRESS AND LUNG FUNCTION ON PHYSICAL FUNCTIONING IN A RETIRED POPULATIONRoberts, M. / Mapel, D. et al. | 2011
-
PRS30 COMPARISON OF CLINICAL AND PATIENT-REPORTED OUTCOME MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASEYang, Y. / Pickard, A. S. / Lee, T. et al. | 2011
-
PRM7 DRUG DEVELOPMENT AND PHARMACEUTICAL PRICING IN THE UNITED STATES: THE INFLUENCE OF DRUG INTENDED OUTCOMES OF DRUG PRICINGIaconi, A. / Khalidi, N. / Olanrewaju, O. / Balkrishnan, R. et al. | 2011
-
PRM28 CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS: THE CALIPSO QUESTIONNAIRESampogna, F. / Styles, I. / Tabolli, S. / Abeni, D. et al. | 2011
-
PRM34 EVALUATING THE SCREENING ABILITY OF PATIENT-REPORTED OUTCOME INSTRUMENTSCoon, C. / McLeod, L. / Arnold, L. / Chandran, A. / Martin, S. et al. | 2011
-
PRM49 TRANSLATION AND LINGUISTIC VALIDATION – METHODOLOGICAL IMPLICATIONS WHEN THE SOURCE MEASURE IS NOT ENGLISHClayson, D. / Verjee-Lorenz, A. / Two, R. / Gerber, R. / Beaudreuil, J. et al. | 2011
-
PCN11 COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL COSTS ACROSS TREATMENTS FOR PROSTATE CANCERWilson, L. S. / Basu, R. / Paoli, C. / Lian, V. / Wong, A. / Kuo, J. / Sadetsky, N. / Cooperberg, M. / Carroll, P. et al. | 2011
-
PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPYVergnenegre, A. / Heigener, D. F. / Bischoff, H. G. / Chouaid, C. / Taylor-Stokes, G. / Roughley, A. / Walzer, S. et al. | 2011
-
PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCERNorthridge, K. / Richhariya, A. / Halperin, M. / Chung, K. / Danese, M. D. et al. | 2011
-
PCN32 COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTSLafeuille, M. H. / Bailey, R. A. / Senbetta, M. / McKenzie, R. S. / Lefebvre, P. et al. | 2011
-
PCN33 COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q- DELETIONBozkaya, D. / Mahmoud, D. / Mitsi, G. / Khan, Z. M. et al. | 2011
-
PCN37 ESTIMATING COST OF TREATMENT IN ELDERLY PATIENTS WITH COLORECTAL CANCER USING MEDICARE DATAKokkotos, F. / Shen, S. / Wang, Z. / Zhang, Y. et al. | 2011
-
PCN71 USING MEASURES OF SOCIETAL VALUE AND ECONOMIC MODELING TO ESTIMATE PRICES FOR CANCER DRUGS IN SOUTH AFRICADranitsaris, G. / Truter, I. / Lubbe, M. / Fourie, S. et al. | 2011
-
PCN76 SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES LEAD TO CONSIDERABLE HEALTH RESOURCE UTILISATION IN EUROPE: ANALYSIS OF A MULTINATIONAL OBSERVATIONAL STUDYHechmati, G. / Hoefeler, H. / Bahl, A. / Lü / ftner, D. / Lorusso, V. / Garzó / n Rodriguez, C. / Ashcroft, J. / Suenaert, P. et al. | 2011
-
PCN92 PSYCHOMETRIC COMPARISION OF THE EQ-5D-3L TO THE EQ-5D-5L IN CANCER PATIENTS IN KOREAKim, S. H. / Jo, M. W. et al. | 2011
-
PCN96 CANCER PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR PREVENTING CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN THE UNITED STATESMiller, P. J. / Balu, S. / Buchner, D. / Walker, M. S. / Stepanski, E. J. / Schwartzberg, L. S. et al. | 2011
-
PCN110 REAL WORLD CLINICAL RESOURCE UTILIZATION OF METASTATIC PROSTATE CANCER PATIENTS IN THE UNITED STATES: RESULTS FROM TWO LARGE CLAIMS DATABASESLafeuille, M. H. / Senbetta, M. / McKenzie, R. S. / Lefebvre, P. et al. | 2011
-
PCN120 WHO CHOSE PRIMARY ANDROGEN DEPRIVATION THERAPY OVER RADICAL PROSTATECTOMY: A RETROSPECTIVE STUDY AMONG VETERANS WITH LOCALIZED PROSTATE CANCERLiu, J. / Shi, L. / Sartor, O. et al. | 2011
-
PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENTLachaine, J. / Beauchemin, C. / Goyette, A. / Martel, M. J. et al. | 2011
-
PMH1 IS STIMULANT OR ATOMOXETINE UTILIZATION ASSOCIATED WITH NEUROLOGICAL ADVERSE EVENTS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)? A RETROSPECTIVE ANALYSIS OF PROPENSITY SCORE MATCHED DATABhattacharjee, S. / Chen, H. / Bhatara, V. / Aparasu, R. R. et al. | 2011
-
PMH4 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATYPICAL ANTIPSYCHOTICS-A MULTIPLE PROPENSTY SCORE ADJUSTED RETROSPECTIVE COHORT STUDYChatterjee, S. / Chen, H. / Johnson, M. L. / Aparasu, R. R. et al. | 2011
-
PMH16 CHARACTERISTICS OF PATIENTS IN COMMUNITY BEHAVIORAL HEALTH ORGANIZATIONS RECEIVING TWO INJECTABLE FORMS OF ATYPICAL ANTIPSYCHOTIC MEDICATIONS AS COMPARED WITH OTHER ANTIPSYCHOTICSMark, T. / Panish, J. / Mao, L. / Montejano, L. B. / Dirani, R. / Fastenau, J. / Starr, H. L. et al. | 2011
-
PMH25 CLINICAL OUTCOMES AND ECONOMIC COSTS OF SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERSBerger, A. / Kushkuley, S. / Sanders, K. / Alvir, J. / Oster, G. et al. | 2011
-
PMH49 CAN THE ILLNESS PERCEPTION QUESTIONNAIRE BE USED TO ASSESS MENTAL HEALTH PRACTITIONERS' PERSPECTIVES ON PATIENTS WITH SCHIZOPHRENIA?Fleming, M. / Martin, C. R. et al. | 2011
-
PMH51 BASELINE RESULTS FROM BEAT THE BLUESPizzi, L. T. / Jutkowitz, E. / Gitlin, L. / Suh, D. C. / Dennis, M. et al. | 2011
-
PMH53 ASSESSING THE IMPACT OF MAJOR DEPRESSIVE DISORDER (MDD) ON FAMILY FUNCTIONING: DEVELOPMENT OF THE DEPRESSION AND FAMILY FUNCTIONING SCALELanç / on, C. / DiBenedetti, D. B. / Lewis, S. / Davis, K. / Danchenko, N. / Franç / ois, C. et al. | 2011
-
PMH58 NEW DISEASE MANAGEMENT PROGRAM FOR OPIOID DEPENDENT PATIENTS DECREASES DRUG USE AND INCREASES 12 STEP MEETING ATTENDANCE: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIALTkacz, J. / Ruetsch, C. et al. | 2011
-
PMH78 PERSISTENCE OF STIMULANT TREATMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDERPalli, S. R. / Aparasu, R. R. / Chen, H. / Sherer, J. T. et al. | 2011
-
PMH79 PSYCHOTROPIC POLYPHARMACY IN CHILDREN AND ADOLESCENTS WITH ATTENTION – DEFICIT / HYPERACTIVITY DISORDERPalli, S. R. / Aparasu, R. R. / Chen, H. / Sherer, J. T. et al. | 2011
-
PND23 ECONOMIC EVALUATION OF DEXMEDETOMIDINE FOR SEDATION IN THE INTENSIVE CARE UNITLachaine, J. / Beauchemin, C. et al. | 2011
-
PND25 ECONOMIC TRENDS ASSOCIATED WITH NATALIZUMAB THERAPY IN A COMMERCIALY MANAGED MULTIPLE SCLEROSIS POPULATIONPill, M. / Gilkin, B. et al. | 2011
-
PND36 INTERNAL LOCUS OF CONTROL AND TREATMENT SATISFACTION WITH NATALIZUMABStephenson, J. J. / Kern, D. M. / Agarwal, S. S. / Kamat, S. A. et al. | 2011
-
PND55 USE OF TIME-TO-EVENT ANALYSES TO DEFINE EPISODES OF CARE IN SICKLE CELL DISEASEEworuke, E. / Kauf, T. et al. | 2011
-
PND57 TEMPORAL TRENDS AND GEOGRAPHIC DISCREPANCIES IN PUBLIC EXPENDITURES WITH MULTIPLE SCLEROSIS DRUG TREATMENT IN BRAZILTakemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Tolentino, A. C. / Santos, P. M. / Moretti, A. I. et al. | 2011
-
DM2 12-MONTH OUTCOMES OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY MANAGEMENT (MTM) PROGRAMMoczygemba, L. / Barner, J. C. / Gabrillo, E. et al. | 2011
-
SB1 COMPARISON OF DIFFERENCE-IN-DIFFERENCE, PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLES IN ESTIMATING COST DIFFERENCES BETWEEN TWO COHORTSCao, Z. / Song, X. et al. | 2011
-
MC4 LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATALokhandwala, T. / Yang, Y. / Thumula, V. / Bentley, J. P. / Strum, M. / Banahan, B. F. / Null, K. D. et al. | 2011
-
EV3 A COMPARATIVE EFFECTIVENESS INDEX TO INFORM CLINICAL DECISIONSHorowicz-Mehler, N. / Doyle, J. / Arikian, S. / Hagan, M. et al. | 2011
-
PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINAShi, L. W. / Ma, Y. Q. / Xu, L. P. / Zhao, D. H. / Zhang, Y. et al. | 2011
-
PHP42 EVALUATING DRUG COST AND RESTRICTION PROCESSES OF COMMONLY USED PRESCRIPTION DRUGS UNDER EACH 2011 CALIFORNIA STAND-ALONE MEDICARE PART D PLANPatel, R. / Kim, M. J. / Walberg, M. / Woelfel, J. et al. | 2011
-
PHP40 HEALTH CARE REFORMS UNDER ECONOMIC CRISIS: THE GREEK CASEKritikou, P. / Latsou, D. / Yfantopoulos, J. et al. | 2011
-
PHP53 A RAPID EVALUATION UNIT INCREASES EMERGENCY DEPARTMENT VISITSTwanmoh, J. / Fleming, A. E. / Brooks, D. / Jiang, Y. / Villacorta, R. / McCombs, J. et al. | 2011
-
PHP66 DEMONSTRATING “DISEASE MODIFYING THERAPIES”? AN HTA PERSPECTIVEMcDonald, P. / Colasante, W. / Oshinowo, B. / Saraf, S. et al. | 2011
-
PHP86 IRRATIONAL USE OF ANTIBIOTICS AND ROLE OF PHARMACISTS: AN INSIGHT FROM A QUALITATIVE STUDY IN NEW DELHI, INDIAKotwani, A. / Wattal, C. / Joshi, P. C. / Holloway, K. et al. | 2011
-
PHP89 THE IMPLEMENTATION OF PUBLIC HEALTH GUIDANCE: PREFERENCE FOR CLINICAL OVER BEHAVIOURAL INTERVENTIONSHamerslag, L. / Kusel, J. / Haynes, S. / Brooks-Rooney, C. / Costello, S. et al. | 2011
-
PHP92 RESULTS OF A PHARMACY MANAGEMENT PROGRAM FOR IMPROVING MEDICATION ADHERENCERegine, M. L. / Bunz, T. J. et al. | 2011
-
PHP98 A TREND ANALYSIS OF NEW MOLECULAR ENTITIES WITHDRAWN FOR SAFETY REASONS FROM 1980 TO 2009 IN THE UNITED STATESSeoane-Vazquez, E. / Rodriguez-Monguio, R. / Qureshi, Z. P. / Szeinbach, S. L. et al. | 2011
-
PCV18 MEDICATION ADHERENCE AND HOSPITALIZATION AMONG CHRONIC HEART FAILURE MEDICARE BENEFICIARIES WITH AND WITHOUT DEPRESSIONChhabra, P. / Dutcher, S. K. / Rattinger, G. B. / Zuckerman, I. H. / Simoni-Wastila, L. / Gottleib, S. S. / Stuart, B. et al. | 2011
-
PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETESSussman, M. / Leahy, M. / Friedman, M. / Menzin, J. / Nichols, C. / Neumann, P. / Sullivan, S. D. et al. | 2011
-
PCV27 IS ANEMIA ASSOCIATED WITH HEART FAILURE? NHANES DATABASE (2005-2006) ANALYSISAlsalman, A. J. / Alhammad, A. M. / Alhashem, Y. N. / Al Hawaj, M. A. / Van Tassell, B. W. / Harpe, S. E. et al. | 2011
-
PCV28 CARDIOVASCULAR RISK FACTORS AMONG CHINESE AND WHITE ADULTS IN THE UNITED STATESMcDonald, M. / Zhou, J. / Rubinstein, E. / Mardekian, J. et al. | 2011
-
PCV29 IMPROVING BLEEDING RISK ASSESSMENT FOR ANTICOAGULANT USE IN ATRIAL FIBRILLATIONLee, E. H. / Kwong, W. J. / Casciano, J. / Martin, B. et al. | 2011
-
PCV40 COST AND PRACTICE OF TREATMENT OF ACUTE ISCHEMIC STROKE IN REAL WORLD SETTINGS IN RUSSIAVorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. et al. | 2011
-
PCV54 EFFECTIVENESS OF DISEASE MANAGEMENT CARE IN THE CASE OF HEART FAILUREUgiliweneza, B. et al. | 2011
-
PCV61 THE IMPACT OF THE MEDICARE DOUGHNUT HOLE ON MEDICATION USE BEHAVIORS AND HEALTH CARE RESOURCE UTILIZATION AMONG BENEFICIARIES TAKING STATIN MEDICATIONJoshi, N. / Banahan, B. F. et al. | 2011
-
PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATASandberg, A. / Kostev, K. / Ehlken, B. / Holz, B. / Oberdiek, A. et al. | 2011
-
PCV65 NEW STATIN USERS' PERSISTENCE AND ADHERENCE: BOTH ARE CRITICAL CONCEPTS IN THE COMPREHENSIVE CHARACTERIZATION OF MEDICATION EXPOSURESlejko, J. F. / Valuck, R. J. / Ho, P. M. / Anderson, H. D. / Nair, K. V. / Campbell, J. D. et al. | 2011
-
PCV69 IMPACT OF COMMUNITY PHARMACIST-LED COUNSELING ON IMPROVING MEDICATION ADHRERENCEJiang, J. Z. / Khandelwal, N. / Rudkin, K. / Duncan, I. et al. | 2011
-
PCV85 TREATMENT FOR DEPRESSION IN WOMEN WITH HYPERTENSIONAtkins, E. / Sambamoorthi, U. et al. | 2011
-
PCV88 PATTERNS OF STATIN PRESCRIPTION AMONG PRIVATELY INSURED COMMERCIAL AND MEDICARE PATIENTSBae, J. P. / Peng, X. / Zhao, Z. / Zagar, A. / Sponseller, C. A. / LeNarz, L. A. et al. | 2011
-
PCV106 RE-HOSPITALIZATION RATES OF ACUTE CORONARY SYNDROME PATIENTS IN REAL WORLD CLINICAL PRACTICE: OBSERVATIONS FROM A NATIONAL ADMINISTRATIVE CLAIMS DATATunceli, O. / Gandhi, S. K. / Bhandary, D. / Stephenson, J. J. / Gold, A. / Fu, A. C. / Kern, D. M. / Singer, J. et al. | 2011
-
PSS18 DISEASE SEVERITY EVALUATION AMONG DERMATOLOGICAL OUT-PATIENTS: A COMPARISON BETWEEN THE ASSESSMENTS OF PATIENTS AND PHYSICIANSTabolli, S. / Sampogna, F. / Pagliarello, C. / Paradisi, A. / Spagnoli, A. / Abeni, D. et al. | 2011
-
PSY9 HEALTH CONSEQUENCES AND COSTS OF TACHOSIL® AS HAEMOSTATIC TREATMENT IN LIVER SURGERY VERSUS TISSUCOL®: A RETROSPECTIVE OBSERVATIONAL COHORT STUDYOrtega, A. / Pardo, F. et al. | 2011
-
PSY13 THE COST OF OBESITY AND ITS MAJOR COMORBIDITIES: ANALYSIS FROM A COMMERCIAL CLAIMS DATABASEPadula, W. V. / Nair, K. V. et al. | 2011
-
PSY27 REAL-WORLD EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (PDPN) TREATED WITH PREGABALIN OR GABAPENTINUdall, M. / Mardekian, J. / Harnett, J. et al. | 2011
-
PUK3 DRUG-INDUCED ACUTE RENAL FAILURE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASEAlhammad, A. M. / Al Hawaj, M. A. / Alsalman, A. J. / Alhashem, Y. N. / Harpe, S. E. / Smith, W. R. / Brophy, D. F. et al. | 2011
-
PUK8 KIT73 STUDY: DOES TYPE OF DONOR INFLUENCE LONG-TERM COSTS OF CARE? RESULTS FROM POST-KIDNEY TRANSPLANT PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)Tedesco-Silva, H. J. / Manfro, R. C. / Asano, E. / Nita, M. E. / Barbosa, E. / Carvalho, J. F. / Szabo, S. M. / Levy, A. R. / Donato, B. M. / Rahal, E. et al. | 2011
-
PUK9 MEDICAL CARE SPENDING ASSOCIATED WITH CHRONIC KIDNEY DISEASE BY STAGE OF DISEASE: A POPULATION-BASED STUDYTaylor, T. N. / Salinitri, F. D. / Satterthwaite, D. W. et al. | 2011
-
PUK12 COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTSArreola-Ornelas, H. / Rosado-Buzzo, A. / Garcia-Mollinedo, M. / Camacho-Cordero, L. / Muciñ / o-Ortega, E. / Mould-Quevedo, J. F. / Galindo-Suarez, R. M. et al. | 2011
-
PUK15 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVEVegter, S. / Tolley, K. / Levin, A. / Lok, C. E. / Morton, A. R. / Soroka, S. D. / Keith, M. S. / Postma, M. J. et al. | 2011
-
PMD6 READMISSION RATES AND COSTS ASSOCIATED WITH FIBRIN SEALANT USE AMONG PATIENTS UNDERGOING ORTHOPEDIC SURGERYYe, X. / Shah, M. / Rupnow, M. F. / Hammond, J. et al. | 2011
-
PMD24 GLYCOSYLATED HEMOGLOBIN OR FASTING GLUCOSE TESTING FOR SCREENING DIABETES IN COLOMBIA: A COST-EFFECTIVENESS ANALYSISVecino-Ortiz, A. I. / Garrison, L. / Alfonso-Cristancho, R. et al. | 2011
-
PMD26 ECONOMIC EVALUATIONS FOR SCREENING AND TREATMENTS OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA: A SYSTEMATIC REVIEWLin, V. / Yeh, W. S. / Kowalski, J. et al. | 2011
-
PSU10 COST-EFFECTIVENESS OF PRIMARY PCI WITHOUT ONSITE SURGICAL BACKUPRamos, P. et al. | 2011
-
PSU16 LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY VERSUS LAPAROSCOPIC-ASSISTED VAGINAL HYSTERECTOMY: POST-SURGICAL OUTCOMES AND COSTSWaters, H. / Song, X. / Pan, K. / Subramanian, D. / Sedgley, R. / Raff, G. J. et al. | 2011
-
PSU25 IDENTIFYING IMPROVEMENT OF PRESSURE ULCER PREVENTION AT THE POINT-OF-CARE WITH MULTIPLE METHODS IN THE DEPARTMENT OF SURGERYPadula, W. V. / Mishra, M. K. / Weaver, C. D. / Yilmaz, T. / Splaine, M. E. et al. | 2011
-
PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETESGarrison, L. / Best, J. H. / Robertson, J. C. / Wenten, M. / Bruhn, D. et al. | 2011
-
PDB28 COST SAVINGS IN TYPE-2 DIABETES (T2D) WITH INSULIN GLARGINE COMPARED WITH INSULIN DETEMIR IN THE UNITED KINGDOMTilling, C. / Evans, L. M. / Keech, M. et al. | 2011
-
PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMIA AMONG PATIENTS WITH TYPE-2 DIABETES IN THE UNITED STATESCurkendall, S. / Zhang, B. / Oh, K. / Williams, S. / Pollack, M. / Graham, J. P. et al. | 2011
-
PDB46 DEVELOPMENT OF THE DIABETIC PERIPHERAL NEUROPATHIC PAIN IMPACT MEASURE: A PATIENT-REPORTED OUTCOME MEASURE OF THE IMPACT OF DPNP ON FUNCTIONINGBrod, M. / Carson, R. / Ramasamy, A. / Setyawan, J. et al. | 2011
-
PDB61 DECOMPOSING GENDER DIFFERENCES IN ANGIOTENSIN II CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS AMONG VETERANS WITH DIABETESSambamoorthi, U. / Tiwari, A. / Maney, M. / Pogach, L. et al. | 2011
-
PIH27 DIFFERENCES IN PATIENT SATISFACTION WITH PRIMARY CARE AND SPECIALTY CAREWu, J. / Adolph, M. D. / Feldman, S. R. / Balkrishnan, R. et al. | 2011
-
PIH29 THE ROLE OF GENERATIONAL INFLUENCE TOWARDS COMPLEMENTARY AND ALTERNATIVE MEDICINEMhatre, S. K. / Artani, S. M. / Sansgiry, S. S. et al. | 2011
-
PIH39 THE EFFECT OF ELECTRONIC-MEDICAL-RECORD SYSTEM SOPHISTICATION ON PREVENTIVE HEALTH CARE FOR WOMENTundia, N. / Heaton, P. / Cavanaugh, T. / Guo, J. J. / Hanseman, D. / Kelton, C. M. et al. | 2011
-
PIN3 A META-ANALYSIS OF EFFICACY AND SAFETY OF LINEZOLID FOR INFECTED DIABETIC FOOT TREATMENTVillasis-Keever, M. A. / Rendon-Macias, M. / Esacamilla-Nuñ / ez, A. / Mould-Quevedo, J. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PIN12 ECONOMIC ANALYSIS OF CEFTIOFUR HYDROCHLORIDE FOR TREATMENT OF BOVINE CLINICAL MASTITIS CAUSED BY GRAM-NEGATIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATESPoulsen Nautrup, B. / Van Vlaenderen, I. / Postorino-Reeves, N. / Gasper, S. et al. | 2011
-
PIN13 IMPACT OF NEWLY DIAGNOSED HEPATITIS C INFECTIONS ON HEALTH CARE COSTSMcCombs, J. / Shin, J. / Saab, S. / Hines, P. / Yuan, Y. et al. | 2011
-
PIN21 COST EFFECTIVENESS ANALYSIS OF VACCINATION PROGRAMS WITH 10-VALENT (PCV10) AND 13-VALENT (PCV13) PNEUMOCOCCAL VACCINES IN COLOMBIACoronel, W. / Jaramillo, J. / Caceres, H. A. / Riveros, L. et al. | 2011
-
PIN41 INFLUENZA VACCINATION RATES AMONG HIGH RISK GROUPS IN THE UNITED STATESDiBonaventura, M. / Wagner, J. S. / Goren, A. et al. | 2011
-
PMS9 COST CONSEQUENCE OF COLCHICINE APPROVAL IN THE MEDICAID PROGRAMS IN THE UNITED STATESZhang, Y. J. / Kelton, C. / Guo, J. J. et al. | 2011
-
PMS23 COST-EFFECTIVENESS ANALYSIS OF ANALGESIC THERAPY FOR POSTOPERATIVE PAIN AFTER TOTAL HIP ARTHROPLASTY IN MEXICOContreras, I. / Mould-Quevedo, J. F. / Goycochea-Robles, M. V. / Torres-Gonzalez, R. / Garduñ / o-Espinosa, J. et al. | 2011
-
PMS22 COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICOVargas-Valencia, J. / Sotelo-Guzmá / n, M. / Mould-Quevedo, J. F. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010Becerra Rojas, F. / Benites Chacaltana, C. / Aiello, E. C. / Zingoni, C. / Bergman, G. / Drost, P. / Valencia, J. E. / Sanabria Montañ / ez, C. et al. | 2011
-
PMS38 IMPACT OF MEDICARE PART D COVERAGE GAP ON MEDICATION TAKING BEHAVIOR: AN EVALUATION ACROSS DUAL AND NON-DUAL ELIGIBLE BENEFICIARIES DIAGNOSED WITH RHEUMATOID ARTHRITISShahpurwala, Z. S. / Datar, M. / Banahan, B. F. et al. | 2011
-
PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONSHiligsmann, M. / Salas, M. / Hughes, D. A. / Manias, E. / Gwadry-Sridhar, F. / Linck, P. / Cowell, W. et al. | 2011
-
PMS71 COMPARISON OF PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLE METHODS WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTSBaser, O. / Xie, L. / Wang, L. / Du, J. et al. | 2011
-
PRS16 COST-EFFECTIVENESS OF VARENICLINE VERSUS EXISTING SMOKING CESSATION STRATEGIES IN CENTRAL AMERICA AND THE CARIBBEAN USING THE BENESCO MODELLutz, M. / Lovato, P. / Cuesta, G. et al. | 2011
-
PRM12 DOES DIFFERENTIAL DISCOUNTING ENHANCE DECISION MAKING?O'Mahony, J. / van Rosmalen, J. et al. | 2011
-
PRM27 SF-12 AND EQ-5D UTILITY SCORING STRATEGY: LESSONS FROM APPLYING 40 SCORINGS TO 3 LARGE DATA SETSMiller, T. R. / Bhattacharya, S. et al. | 2011
-
PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEWChan, E. K. / Darmawanti, I. / Mulyana, O. P. / Zumbo, B. D. et al. | 2011
-
PRM45 PILOT TESTING TRANSLATIONS OF PRO MEASURES WITH SENSITIVE POPULATIONSVerjee-Lorenz, A. / Clayson, D. / Two, R. et al. | 2011
-
PRM44 OPTIMUM METHODS FOR PRO TRANSLATION AND LINGUISTIC VALIDATION METHODOLOGY: ONE BACK TRANSLATION OR TWO?Furtado, T. / Anderson, H. / Griffin, A. / Wild, D. et al. | 2011
-
PCN5 USING HEALTH CLAIMS DATA TO STUDY PATTERNS OF CERVICAL CANCER SCREENING AND DIAGNOSIS IN A STATE MEDICAID FEE-FOR-SERVICE POPULATION (FUNDING: AHRQ – P20-HS15930)Nadpara, P. / Madhavan, S. / Khanna, R. / Atkins, E. / Smith, M. J. / Miller, L. A. et al. | 2011
-
PCN6 BREAST, PROSTATE AND COLORECTAL CANCER SCREENING BEHAVIOR AND INCIDENCE OF LATE STAGE CANCER DIAGNOSIS IN ELDERLY WEST VIRGINIANSNadpara, P. / Madhavan, S. / Tworek, C. et al. | 2011
-
PCN14 UNMET NEED IN METASTATIC PROSTATE CANCER PATIENTS: RESULTS FROM A SYSTEMATIC REVIEWWu, Y. / Modha, R. / Sehgal, M. / Dhawan, R. et al. | 2011
-
PCN17 MULTI-COHORT MODEL OF PREVALENCE ESTIMATION OF ADVANCED MALIGNANT MELANOMA IN THE UNITED STATES: RESULTS COMPARED TO SEER DATALin, A. Y. / Wang, F. / Kolker, J. A. et al. | 2011
-
PCN19 AN EPIDEMIOLOGICAL MODEL OF BREAST CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOMMartin, M. / Kearney, M. / Bracco, A. / Brown, J. et al. | 2011
-
PCN24 FACTORS ASSOCIATED WITH LATE-STAGE PROSTATE CANCER SURVIVAL IN FLORIDAAdunlin, G. B. / Xiao, H. et al. | 2011
-
PCN43 STUDY ON MEDICAL EXPENDITURE AND PAYMENT PATTERNS OF INSURED PATIENTS WITH CANCER IN CHINAXiong, X. / Lin, J. / Chen, W. et al. | 2011
-
PCN59 COST EFFECTIVENESS ANALYSIS OF LAPATINIB/CAPECITABINE (LC) VERSUS TRASTUZUMAB/CAPECITABINE (TC) IN PATIENTS WITH METASTATIC BREAST CANCER ERBB2+ AFTER PROGRESSION TO THE FIRST SCHEME OF TRASTUZUMABAnaya, P. / Aldaco, F. et al. | 2011
-
PCN62 BAYESIAN MODELLING ASSESSING THE EFFECTIVENESS OF A VACCINATION STRATEGY TO PREVENT HPV-RELATED DISEASES: THE BEST STUDYMennini, F. S. / Baio, G. / Capone, A. / Marcellusi, A. / Favato, G. / Costa, S. / Garganese, G. / Picardo, M. / Drummond, M. / Jonsson, B. et al. | 2011
-
PCN66 COST-MINIMIZATION ANALYSIS OF THE USE OF RASBURICASE IN TUMOR LYSIS SYNDROME IN PEDIATRIC ONCOLOGYRodrigues, A. H. / Follador, W. / Abadi, M. / Petrilli, A. S. et al. | 2011
-
PCN97 IMPACT OF GLOBAL HEALTH CARE REFORMS ON PRICING, ACCESS AND HEALTH ECONOMICS AND OUTCOMES STRATEGYAggarwal, S. et al. | 2011
-
PCN100 RACIAL DISPARITIES IN AFRICAN AMERICAN VERSUS WHITE WOMEN WITH NEWLY DIAGNOSED BREAST CANCER IN A SOUTHEAST UNITED STATES HEALTH PLANFisher, M. / Cai, Q. / Paoli, C. J. / Lyons, A. / Wasser, T. / Rodriguez, N. / White, S. / Kallich, J. / Barron, J. / Brawley, O. W. et al. | 2011
-
PCN105 ESTIMATING NICE'S COST EFFECTIVE THRESHOLD FOR END-OF-LIFE CANCER TREATMENTSMoï / se, P. / Fassler, P. et al. | 2011
-
PCN122 MELODY BRAZIL: CHEMOTHERAPY CHOICES FOR PATIENTS WITH METASTATIC MELANOMA IN THE PUBLIC HEALTH CARE SYSTEM (SUS)Schmerling, R. A. / Stefani, S. D. / Barbosa, E. / Asano, E. / Nita, M. E. / Nishikawa, A. M. / Dias, K. M. / Donato, B. M. / Rahal, E. et al. | 2011
-
PCN127 METHODS FOR INDIRECT COMPARISON OF EFFECTIVENESS IN COST-EFFECTIVENESS ANALYSES OF ONCOLOGY AGENTS: THE PROPORTIONAL HAZARDS ASSUMPTION MATTERSDucournau, P. / Zhao, Z. / Barber, B. / Gao, S. / Graham, C. N. et al. | 2011
-
PCN133 ESTIMATING THE EPIDEMIOLOGY OF LATE-STAGE CANCERS – A MATHEMATICAL APPROACHPan, F. / Sorensen, S. / Stern, S. et al. | 2011
-
PGI3 THE LIKELIHOOD OF HAVING FUNCTIONAL DYSPEPSIA BASED ON OTHER COMORBID CONDITIONSBrook, R. A. / Talley, N. J. / Choung, R. S. / Smeeding, J. / Kleinman, N. L. et al. | 2011
-
PGI10 EXAMINATION OF RESOURCE UTILIZATION PATTERNS ACROSS SUBGROUPS OF GASTROESOPHAGEAL REFLUX DISEASE PATIENTSGerson, L. B. / Balu, S. / McLaughlin, T. / Lunacsek, O. / Jackson, J. et al. | 2011
-
PMH6 DIFFERENTIAL RATES OF SIDE EFFECTS IN DEPRESSED ADULTS AND ADOLESCENTS BEING TREATED WITH ANTIDEPRESSANTSAnderson, H. D. / Libby, A. M. / Pace, W. D. / West, D. R. / Valuck, R. J. et al. | 2011
-
PMH7 LIKELIHOOD OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PERSONS INITIATING THERAPY WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS: EFFECT OF INITIAL SSRI AND OTHER FACTORSValuck, R. J. / Libby, A. M. / Anderson, H. D. / Erder, M. / Milea, D. / Doshi, J. A. / Collins, C. / Preskorn, S. et al. | 2011
-
PMH27 IDENTIFICATION AND COST OF TREATMENT-RESISTANT DEPRESSION USING A CLAIMS SIGNATUREBates, J. A. / Cooke, C. E. / Hahn, N. M. / Lee, H. Y. / Forbes, R. A. / Jing, Y. et al. | 2011
-
PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTSErder, M. / Chen, K. / Wu, E. Q. / Hodgkins, P. / Sikirica, V. et al. | 2011
-
PMH44 PHYSICAL AND MENTAL HEALTH AS IMPORTANT INPUTS INTO WAGE FUNCTIONGhushchyan, V. H. / Campbell, J. D. / Libby, A. M. et al. | 2011
-
PMH54 CAREGIVER BURDEN IN SCHIZOPHRENIA - A SYSTEMATIC REVIEWShah, D. / Kamal, K. M. et al. | 2011
-
PMH63 RISK-BENEFIT ANALYSIS OF DEPRESSION TREATMENT FOR CHILDREN AND YOUNG ADULTSSoeteman, D. I. / Miller, M. / Kim, J. et al. | 2011
-
PND4 DIAGNOSIS OF SHIFT WORK DISORDER AND THE IMPACT OF EXCESSIVE SLEEPINESS: RESULTS FROM SHIFT WORKERS, PATIENTS WITH SHIFT WORK DISORDER, AND HEALTH CARE PROFESSIONALS PARTICIPATING IN AN INTERNET SURVEYAnderson, C. / Sylvester, L. / Paik, S. et al. | 2011
-
PND9 FACTORS AFFECTING FUNCTIONAL DEPENDENCE IN ALZHEIMER PATIENTS RESIDING IN NURSING HOMES IN THE UNITED STATES - USING NATIONAL NURSING HOME SURVEY (NNHS-2004)Kale, H. / Nair, R. et al. | 2011
-
PND14 BURDEN OF ILLNESS IN THE UNITED STATES FOR ADULT EPILEPSY PATIENTS WITH PARTIAL ONSET SEIZURES RECEIVING ANTI-EPILEPTIC DRUGSCopher, R. / Angalakuditi, M. et al. | 2011
-
PND20 HEALTHCARE UTILIZATION AND COSTS AMONG AD PATIENTS WITH AND WITHOUT DYSPHAGIAGabriel, S. / Tian, H. / Kim, E. / Kahler, K. H. et al. | 2011
-
PCV4 TREATMENT PATTERNS, CLINICAL AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM IN ABDOMINAL SURGERY PATIENTSWang, L. / Dysinger, A. H. / Du, J. / Xie, L. / Baser, O. et al. | 2011
-
PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF)LaMori, J. C. / Gross, H. J. / Patel, A. A. / Crain, M. / DiBonaventura, M. D. / Mody, S. H. / Schein, J. et al. | 2011
-
PCV19 A BAYESIAN MULTIPLE TREATMENT COMPARISON OF PULMONARY ARTERIAL HYPERTENSION DRUG CLASSES BASED ON THE RISK OF MORTALITY REPORTED IN CLINICAL TRIALSMutebi, A. / Malone, D. et al. | 2011
-
PCV67 EXAMINING MEDICATION ADHERENCE AMONG TRICARE BENEFICIARIES RECEIVING STATIN THERAPY FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MILITARY TREATMENT FACILITIES IN THE UNITED STATESNwokeji, E. / Yarger, S. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. et al. | 2011
-
PCV83 GAPS AND UNMET NEEDS IN ANTIPLATELET THERAPIES FOR ACUTE CORONARY SYNDROME (ACS) AND CHRONIC CORONARY HEART DISEASE (CHD)Lian, J. / Azmi, S. / Navaratnam, P. et al. | 2011
-
PCV89 COMPARISON OF DOSING PATTERNS AMONG PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATIONZhao, Z. / Peng, X. / Bae, J. P. / Dungey, J. / Faries, D. E. / Sponseller, C. A. / Wetmore, S. / Yu, C. Y. / LeNarz, L. A. et al. | 2011
-
PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATESKorves, C. / Eldar-Lissai, A. / Rodermund, D. / Swallow, E. / Cummings, A. K. / Ariely, R. / Duh, M. S. et al. | 2011
-
PCV101 EXPLORING GENDER DISPARITIES IN PREVENTIVE CARE UTILIZATION AMONGST THE UNITED STATES POPULATIONVaidya, V. / Partha, G. / Karmakar, M. et al. | 2011
-
PSS10 A COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE AND SEVERE PSORIASIS IN MEXICOVargas-Valencia, J. / Sotelo-Guzmá / n, M. / Mould-Quevedo, J. F. / Muciñ / o-Ortega, E. / Galindo-Suarez, R. M. et al. | 2011
-
PSY7 A NOVEL MECHANISM OF CAPTURING POST-MARKETING SAFETY INFORMATION ON RECOMBINANT FACTOR VIIA (RFVIIA) IN THE RARE DISORDER ACQUIRED HEMOPHILIA: THE ACQUIRED HEMOPHILIA SURVEILLANCE (AHS) PROJECTLentz, S. / Tandra, A. / Doucette, K. / Cooper, D. L. et al. | 2011
-
PSY39 EPIDEMIOLOGY OF HEREDITARY COAGULOPATHIES IN KAZAKHSTAN: PATIENT-REPORTED DATAVorobyev, P. / Borisenko, O. / Zhulyov, Y. / Rybalova, T. / Krasnova, L. / Bezmelnitsyna, L. et al. | 2011
-
PSY51 EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGEGoyal, R. K. / Rajan, S. S. / Essien, E. J. / Sansgiry, S. et al. | 2011
-
PSY60 ECONOMIC CONSEQUENCES OF UNDER-UTILIZATION WITH TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTSCarter, C. / Gunnarsson, C. / Rizzo, J. / Bolge, S. / Ingham, M. et al. | 2011
-
PSY65 CHARACTERISTICS OF GOLIMUMAB UTILIZATION IN A LARGE NATIONAL PAYER DATABASETandon, N. / Saulnier, A. / Gunnarsson, C. et al. | 2011
-
PUK2 DUTASTERIDE FOR BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSISPark, T. / Shamliyan, T. A. et al. | 2011
-
PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITYGlobe, D. / Carlson, J. / Patel, H. / Colayco, D. / Hansen, R. N. / Watanabe, J. / Sullivan, S. D. et al. | 2011
-
PMD14 COMPARISON OF PER DISCHARGE COSTS OF THE REPAIR OF INCISIONAL/VENTRAL HERNIAS PERFORMED WITH PERMACOL™ AND STRATTICE™ IN THE UNITED STATESMorseon, M. / Hashemi, L. et al. | 2011
-
PMD23 COST-EFFECTIVENESS OF SPECIFIC USE OF THE LANCET BD QUIKHEEL® IN SCREENING PROGRAM OF NEONATAL CONGENITAL HYPOTHYROIDISM IN MEXICOVallejos Pará / s, A. / Contreras, I. / Ojeda Mé / ndez, J. / Yam Ontiveros, C. et al. | 2011
-
PDB9 IMPACT OF EXENATIDE, PEN INSULIN AND VIAL/SYRINGE INSULIN ON PATIENT OUTCOMES IN A DIABETES POPULATION IN THE UNITED STATES: A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE AND FIRST-YEAR COSTSRashid, N. / McCombs, J. / Foster, S. / Miller, L. A. et al. | 2011
-
PDB12 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS: A NESTED CASE-CONTROL STUDYKhoza, S. / Barner, J. C. / Lawson, K. / Rascati, K. L. / Wilson, J. P. / Bohman, T. M. et al. | 2011
-
PRM43 BIOSIMILARS: DEMONSTRATING SIMILARITY THROUGH EVIDENCEKleintjens, J. / Dahal, D. / Mai, J. C. / Doyle, J. J. et al. | 2011
-
PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASEBest, J. H. / Pelletier, E. / Smith, D. B. et al. | 2011
-
PDB30 A CROSS-SECTIONAL SURVEY ON ECONOMIC BURDEN OF TYPE-2 DIABETES MELLITUS PATIENTS WITH ORAL ANTI-DIABETIC DRUGS THERAPY IN CHINAJi, L. / Ye, Q. / Chang, J. H. / Liu, G. G. et al. | 2011
-
PDB39 A DESCRIPTIVE ANALYSIS OF TREATMENT ADHERENCE WITH GROWTH HORMONE: FINDINGS FROM A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATESFincher, C. / Kozma, C. / Meletiche, D. M. / Velez, F. et al. | 2011
-
PDB60 EFFECT OF MEDICARE PART D COVERAGE GAP ON MEDICATION CONSUMPTION BEHAVIORS: CASE OF ORAL ANTI-DIABETIC MEDICATIONSMahabaleshwarkar, R. / Banahan, B. F. et al. | 2011
-
PDB63 GEOGRAPHIC VARIATION IN DRUG SPENDING AND ADHERENCE PATTERNS FOR MEDICARE BENEFICIARIES WITH DIABETESShoemaker, J. S. / Dai, M. / Stuart, B. et al. | 2011
-
PDB65 ECONOMIC BURDEN OF CUSHING'S DISEASE: A POPULATION ANALYSIS OF DIRECT MEDICAL COSTS AND UTILIZATIONSwearingen, B. / Wu, N. / Chen, S. Y. / Pulgar, S. / Biller, B. M. et al. | 2011
-
PIH41 SUCCESSFUL SEXUAL INTERCOURSE: TIME-TO-EVENT MODELING IN A SILDENAFIL TRIALCappelleri, J. C. / Bushmakin, A. G. / Stecher, V. / Symonds, T. et al. | 2011
-
PIN2 HEALTH OUTCOMES OF CLINICALLY RELEVANT PATIENT POPULATIONS TREATED WITH DAPTOMYCIN FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) SKIN INFECTIONSMcKinnon, P. S. / Goff, D. A. / Boening, A. J. / Lodise, T. A. et al. | 2011
-
PIN28 ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN BRAZIL USING A TRANSMISSION DYNAMIC MODELSinghal, P. K. / Tannus, G. / Fonseca, M. / Kawai, K. / Dasbach, E. et al. | 2011
-
PIN49 A REVIEW OF EPIDEMIOLOGICAL LITERATURE ON THE BASIC REPRODUCTION NUMBER FOR THE 2009 NOVEL STRAIN OF H1N1Walker, A. / Murphy, J. / Hettle, R. / Plested, M. et al. | 2011
-
PMS12 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DUPUYTREN'S CONTRACTUREMacaulay, D. / Ivanova, J. / Birnbaum, H. / Sorg, R. / Skodny, P. et al. | 2011
-
PMS17 EVALUATING THE ASSOCIATION BETWEEN SERUM URIC ACID LEVEL AND HEALTH CARE COSTS IN PATIENTS WITH GOUTCheng, I. N. / Duffin, M. / Pulicharam, J. S. / Tong, G. / Aranda, G. A. et al. | 2011
-
PMS28 COST-EFFECTIVNESS ANALYSIS OF NSAIDS FOR SYMTOMATIC TREATMENT OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITISTolubaiev, V. / Zalis'ka, O. et al. | 2011
-
PMS49 ADOPTION, CHOICE, AND UTILIZATION OF BIOLOGIC THERAPIES FOR RHEUMATOID ARTHRITIS IN THE MEDICARE POPULATIONMcElligott, S. / Li, P. / Schwartz, S. / Doshi, J. A. et al. | 2011
-
PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALSKeystone, E. / Fleischmann, R. / Han, C. / Smolen, J. S. / Emery, P. / Genovese, M. / Gathany, T. / Doyle, M. / Hsia, E. et al. | 2011
-
PMS61 INFLIXIMAB INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS ‘NAïVE' TO BIOLOGIC THERAPY: AN ANALYSIS OF A NATIONAL HEALTH PLANSchmeichel-Mueller, C. / Tkacz, J. / Ruetsch, C. et al. | 2011
-
PMS64 PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTSTandon, N. / Bolge, S. / Annunziata, K. et al. | 2011
-
PMS69 THE USE OF MIXED TREATMENT COMPARISONS IN NICE TECHNOLOGY APPRAISALSBrooks-Rooney, C. / Costello, S. / Kusel, J. / Timm, B. et al. | 2011
-
PMS74 PILOT VALIDATION OF THE BRIEF PAIN INVENTORY ‘PAIN AT ITS WORST’ ITEM IN PATIENTS WITH RHEUMATOID ARTHRITISSterling, K. / Naegeli, A. N. / Zagar, A. et al. | 2011
-
PRS25 FACTORS INFLUENCING SATISFACTION WITH COPD MAINTENANCE MEDICATION: CONCEPTS ELICITED THROUGH QUALITATIVE INTERVIEWS WITH PATIENTSMocarski, M. / Palsgrove, A. / Schaefer, M. / Setyawan, J. / Wilcox, T. et al. | 2011
-
PRS37 THE PRICE NEGOTIATION ON PHARMACEUTICALS AFTER THE INTRODUCTION OF POSITIVE LIST SYSTEM IN SOUTH KOREAYoon, S. Y. / Lee, E. K. et al. | 2011
-
PRS46 MEASUREMENT COMPARABILITY BETWEEN PAPER AND ALTERNATE VERSIONS: RECOMMENDED ASSESSMENT STEPS USING THE LUNG FUNCTION QUESTIONNAIRE AS AN EXAMPLEDalal, A. A. / Nelson, L. M. / Gilligan, T. / McLeod, L. D. / Lewis, S. / DeMuro, C. et al. | 2011
-
PRM20 TRENDS IN UTILITY ELICITATION METHODS: DIRECT VERSUS INDIRECT METHODSProsser, L. A. / Wittenberg, E. et al. | 2011
-
PRM21 CONVERTING PAPER VERSIONS OF PATIENT REPORTED OUTCOME INSTRUMENTS TO ELECTRONIC VERSIONS: IDENTIFYING THE REQUIRED STEPSRoss, J. / O'Gorman, H. J. / Peck, R. / Ross, E. et al. | 2011
-
PCN18 AN EPIDEMIOLOGICAL MODEL OF PROSTATE CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOMCure, S. / Martin, M. / Bracco, A. / Brown, J. / Kearney, M. et al. | 2011
-
PCN20 EXERCISE LOWERS ESTROGEN AND PROGESTERONE LEVELS IN PREMENOPAUSAL WOMEN AT HIGH RISK OF BREAST CANCERKossman, D. / Williams, N. / Domchek, S. / Kurzer, M. / Stopfer, J. / Schmitz, K. et al. | 2011
-
PCN88 ATTITUDES OF YOUNG WOMEN ON HUMAN PAPILLOMA VIRUS VACCINATIONChopra, P. / Shah, J. / Fase, B. / Sansgiry, S. et al. | 2011
-
PCN87 HOW DOES PATIENT-REPORTED OUTCOME DATA INFLUENCE THE CLINICAL DECISION MAKING OF PRACTICING ONCOLOGISTS?Meldahl, M. L. / Acaster, S. / Hayes, R. P. et al. | 2011
-
PCN86 A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCERWang, J. / Zhao, Z. / Sherrill, B. / Peeters, M. / Wiezorek, J. / Barber, B. et al. | 2011
-
PCN102 SYNCHRONIZATION OF ADMINISTRATIONS OF CHEMOTHERAPY AND ERYTHROPOIESIS-STIMULATING AGENTS AND FREQUENCY OF ASSOCIATED HEALTH CARE VISITSHill, J. / Shreay, S. / McGarvey, N. / De, A. P. / Hess, G. P. / Corey-Lisle, P. et al. | 2011
-
PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATALau, E. L. / Mowat, F. S. / Kelsh, M. A. / Legg, J. / Engel-Nitz, N. M. / Watson, H. N. / Collins, H. / Nordyke, R. J. / Whyte, J. L. et al. | 2011
-
PGI13 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS NO TREATMENT IN CHRONIC HEPATITIS BVorobyev, P. / Telegina, I. / Borisenko, O. / Jakouloff, D. et al. | 2011
-
PMH5 PSYCHIATRIC ADVERSE EFFECTS RELATED TO PRESCRIPTION OF METHYLPHENIDATE IN TAIWANYang, C. L. / Huang, W. F. / Tsai, Y. W. et al. | 2011
-
PMH28 REAL-WORLD HEALTH CARE UTILIZATION AND COSTS IN NEWLY DIAGNOSED DEPRESSION PATIENTS BETWEEN 2006 AND 2008Schneider, G. / Roy, A. / Busner, J. / Crean, S. / Lanes, S. / Dabbous, O. H. et al. | 2011
-
PMH31 TRAJECTORY ANALYSIS OF HEALTH CARE COSTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH HIGH DOSES OF DULOXETINECui, Z. / Faries, D. / Zhao, Y. / Niu, L. / Novick, D. / Liu, X. et al. | 2011
-
PMH57 ASSOCIATION BETWEEN WORK PRODUCTIVITY AND SEVERITY OF DEPRESSION AMONG FULL-TIME EMPLOYEES AS MEASURED BY THE WPAI & HPQJain, G. / Roy, A. / Harikrishnan, V. / Yu, S. / Dabbous, O. H. et al. | 2011
-
PMH72 ANTIDEPRESSANT PERSISTENCE AND ASSOCIATED HEALTH CARE EXPENDITURES IN CHILDREN WITH DEPRESSIONKarkare, S. / Aparasu, R. R. / Chen, H. / Rajan, S. S. et al. | 2011
-
PND51 THE EFFECT OF THE MEDICARE PART D COVERAGE GAP AND OUT-OF-POCKET BURDEN ON THE USE OF DISEASE MODIFYING DRUGS TO TREAT MULTIPLE SCLEROSISBanahan, B. F. / Datar, M. / Mendonca, C. M. / Shahpurwala, Z. / Bentley, J. P. / Phillips, A. L. / Stewart, M. et al. | 2011
-
PND52 HEALTH CARE RESOURCE UTILIZATION BEFORE AND AFTER INITIATION OF ARMODAFINIL TREATMENT FOR WAKEFULNESSCarlton, R. / Regan, T. S. / Lunacsek, O. / Dammerman, R. et al. | 2011
-
CN2 ESTIMATED EFFECTS OF THE NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM ON CERVICAL CANCER MORTALITYEkwueme, D. U. / Uzunangelov, V. / Hoerger, T. / Saraiya, M. / Miller, J. / Hall, I. / Benard, V. / Royalty, J. / Li, C. et al. | 2011
-
DM1 IMPACT OF A PHARMACY REFILL MANAGEMENT SYSTEM ON OUTCOMES IN END STAGE RENAL DISEASE (ESRD) PATIENTSRubin, J. L. / Wilson, S. M. / Golomb, J. et al. | 2011
-
DS1 INTEGRATING DATA SOURCES TO CONDUCT COMPREHENSIVE ONCOLOGY BASED OUTCOMES RESEARCHAlbright, F. / Bollu, V. / Kuo, K. L. / Raimundo, K. / Barney, R. / Stenehjem, D. / Brixner, D. et al. | 2011
-
DU4 THE LONG TERM UTILIZATION OF STIMULANTS IN CHILDREN AND ADOLESCENTS: A MEDICAID STUDYSudharshan, L. / Chen, H. et al. | 2011
-
MD3 EVALUATING THE WILLINGNESS-TO-PAY OF MEDICARE BENEFICIARIES FOR PART D PLAN ASSISTANCEPatel, R. A. / Walberg, M. P. / Na, J. / Hsiou, D. / Panchal, V. / Woelfel, J. A. / Galal, S. M. / Carr-Lopez, S. M. / Chan, E. K. et al. | 2011
-
QA1 COST-EFFECTIVENESS OF DUTASTERIDE AS A CHEMOPREVENTION IN PROSTATE CANCER: REDUCE WITHIN-TRIAL ANALYSISEarnshaw, S. R. / Chirila, C. / McDade, C. / Black, L. / Andriole, G. L. et al. | 2011
-
QA2 CROSS-WALKING CANCER-SPECIFIC INSTRUMENTS TO THE EQ-5D AND SF-6DTeckle, P. / Peacock, S. / van der Hoek, K. / Chia, S. / Melosky, B. / Gelmon, K. et al. | 2011
-
PHP9 IMPACT OF FREE PRESCRIPTIONS IN WALES ON PRESCRIBING - A THIN DATABASE STUDYThompson, M. / Sedani, T. / Blak, B. T. / Hards, M. et al. | 2011
-
PHP26 ANALYSIS OF THE SIX PROTECTED MEDICATION CLASSES BASED ON PLAN TYPE AND LOW INCOME SUBSIDY STATUSBlackwell, S. / Waldron, C. / Evans, M. et al. | 2011
-
PHP31 REVIEW OF HIGHLY SPECIALIZED MEDICAL SERVICES IN KAZKAHSTAN WITHIN AN INTRODUCTIN OF UNIFIED NATIONAL HEALTH SYSTEMYergaliyev, K. / Issayeva, R. / Umralin, T. et al. | 2011
-
PHP33 IMPACT OF PHARMACY AND MEDICAL PLAN INTEGRATION ON OVERALL MEDICAL COSTSBunz, T. J. / Nguyen, H. V. / Regine, M. L. et al. | 2011
-
PHP32 ANALYSIS OF PHARMACISTS' INTERVENTIONS ON ELECTRONIC VERSUS TRADITIONAL PRESCRIPTIONS IN TWO COMMUNITY PHARMACIESGilligan, A. / Miller, K. / Mohney, A. / Montenegro, C. / Schwarz, J. / Warholak, T. L. et al. | 2011
-
PHP36 CATASTROPHIC INJURY-RELATED ENROLLMENT AND COSTS IN A STATE MEDICAID FEE-FOR-SERVICE PROGRAMSmith, M. J. / Zaloshnja, E. / Miller, T. R. et al. | 2011
-
PHP49 UTILIZATION AND COST OF THE HEALTH PLAN - EFFECTS OF SPOUSAL BEREAVEMENTReis Neto, J. / Arantes, A. C. et al. | 2011
-
PHP79 ROLE OF HTA SYSTEMS IN REIMBURSEMENT AND MARKET ACCESS: COMPARISON OF TURKEY AND POLANDKirpekar, S. / Shankland, B. / Dummett, H. et al. | 2011
-
Copyright/Subscription| 2011
-
CE1 COST-EFFECTIVENESS SENSITIVITY ANALYSIS METHODS: A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATIONCampbell, J. / McQueen, R. B. / Libby, A. / Briggs, A. et al. | 2011
-
MD4 EVALUATION OF AN INTERVENTION TO REDUCE POLY-PHARMACY IN MEDICARE PART DLivengood, K. B. / Harrell, T. / Abarca, J. et al. | 2011
-
PHP7 DEVELOPING PUBLIC HEALTH GUIDANCE - WHAT ARE THE DATA GAPS? REVIEW OF THE GAPS IN THE EVIDENCE IDENTIFIED BY NICE IN THE UNITED KINGDOMKusel, J. / Costello, S. / Hamer, N. / Roper, S. / Hamerslag, L. et al. | 2011
-
PHP25 THE POTENTIAL VALUE OF THE 2014 MEDICAID EXPANSIONSepulveda, B. / Doyle, J. et al. | 2011
-
PHP46 THE STATE OF HEALTH ECONOMIC EVALUATION IN SOUTH AFRICA: A SYSTEMATIC REVIEWGavaza, P. / Rascati, K. L. / Oladapo, A. O. / Khoza, S. et al. | 2011
-
PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)Ofierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. et al. | 2011
-
PHP84 AHRQ VERSUS NICE: DO THE CONCLUSIONS IN CER REPORTS CORRESPOND CLOSELY TO THE COMPARATIVE EFFECTIVENESS ASSESSMENTS MADE IN HTA REPORTS?Alnwick, K. et al. | 2011
-
PHP88 INFLUENCE OF HOSPITAL CHOICES OF DRUGS ON THE PHARMACEUTICAL CONSUMPTION IN THE COMMUNITYGallini, A. / Legal, R. / Taboulet, F. et al. | 2011
-
PHP91 ASSOCIATION BETWEEN QUALITY OF CARE AND SHORT TERM OUTCOMES FOR VERY OLD PATIENTS HOSPITALIZED FOR ACUTE ILLNESSESChong, W. F. / Ding, Y. Y. / Sun, Y. / Heng, B. H. et al. | 2011
-
PHP113 IQWIG AND HIQA, WHAT ARE THEY GOOD FOR? THE EVOLUTION OF THE HTA AGENCY: TIME FROM CREATION TO FIRST ASSESSMENT AND IMPACTFUL APPRAISALGreen, M. J. et al. | 2011
-
PCV6 ANALYSIS OF MYOCARDIAL INFARCTION RELATED CLINICAL OUTCOMES, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONWang, L. / Xie, L. / Baser, O. et al. | 2011
-
PCV11 PNEUMONIA AFTER ACUTE ISCHEMIC STROKE: PREVALENCE, ASSOCIATED FACTORS AND OUTCOMESAl-Jabi, S. W. / Hassan, Y. / Abd Aziz, N. / Looi, I. / Zyoud, S. H. et al. | 2011
-
PCV48 COST-EFFECTIVENESS ANALYSIS OF ANTIARRHYTHMIC THERAPIES FOR THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA AND SURGICALLY INDUCED TACHYCARDIAS AND HYPERTENSIONDexter, F. / Yang, J. / Carlton, R. / Bramley, T. / Harb, G. et al. | 2011
-
PCV53 COST-EFFECTIVENESS ANALYSIS COMPARING IVABRADINE WITH ISOSORBIDE MONONITRATE, AMLODIPINE, DILTIAZEM AND VERAPAMIL, IN THE TREATMENT OF STABLE ANGINA PECTORISErgene, O. / Erol, M. K. / Oto, A. / Kucukoglu, S. / Ozdemir, O. / Tan, M. et al. | 2011
-
PCV76 PATIENT SYMPTOM EXPERIENCES FOLLOWING A MYOCARDIAL INFARCTIONGwaltney, C. / Martin, M. L. / Falvey, H. et al. | 2011
-
PCV78 HEALTH RELATED QUALITY OF LIFE IN HYPERTENSIVE PATIENTS VISITING PUBLIC HOSPITALS OF QUETTA, PAKISTANSaleem, F. / Hassali, M. A. / Shafie, A. A. / Bashir, S. et al. | 2011
-
PCV109 BEYOND CASE FATALITY: A NEW METHOD TO ESTIMATE THE EFFECT OF INCREASING TREATMENT UPTAKE ON MORTALITYMitsakakis, N. / Wijeysundera, H. C. / Krahn, M. et al. | 2011
-
PCV107 IDENTIFYING EFFICIENT ACUTE CLINICAL PATHWAYS FOR CHEST PAIN: USING RISK ADJUSTED COST-EFFECTIVENESS (RAC-E) TO COMPARE HOSPITALS USING LINKED, ROUTINELY COLLECTED DATACaffrey, O. / Pham, C. / Karnon, J. / Ben-Tovim, D. I. / Hakendorf, P. / Crotty, M. et al. | 2011
-
PSS11 COST-EFFECTIVENESS ANALYSIS OF FORMULARY MANAGEMENT STRATEGIES FOR FIRST-LINE AGENTS USED IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSIONBlaser, D. A. / Ousterhout, M. M. / Gagnon, J. M. / Calabrese, D. et al. | 2011
-
PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACHDuran, A. / Spaepen, E. / Lamotte, M. / Walter, E. / Lucioni, C. / Pinheiro, B. / Brosa, M. / Kutikova, L. / Pujol, B. / Annemans, L. et al. | 2011
-
PSY32 HOW DO MINIMALLY IMPORTANT DIFFERENCES VALUE OUTCOMES?Suh, J. K. / Doctor, J. et al. | 2011
-
PSY38 PATIENT-REPORTED OUTCOMES IN SUBJECTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY: PAIN DESCRIPTION AND QUALITY OF LIFEKo, K. S. / Cha, B. Y. / Kim, C. H. / Kwon, H. S. / Lee, J. H. / Park, T. S. / Won, J. C. / Ko, S. K. / Park, H. J. et al. | 2011
-
PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTSWisniewski, T. / Petrilla, A. A. / DeKoeven, M. / Lee, W. C. / Cooper, D. L. / Holot, N. / von Mackensen, S. et al. | 2011
-
PSY74 TREATMENT CHOICE FOR PAIN MANAGEMENT IN NURSING HOME HOSPICE/PALLIATIVE CARE RESIDENTS IN THE UNITED STATESAgrawal, R. / Mhatre, S. K. / Sansgiry, S. et al. | 2011
-
PSY77 COMPARISON OF OBESITY-ASSOCIATED COMORBIDITIES BETWEEN EMR AND CLAIMS DATABASESBrixner, D. / Bron, M. / Bellows, B. K. / Ye, X. / Harikrishnan, V. / Oderda, G. et al. | 2011
-
PSY81 PERCEPTIONS ABOUT 'RAPID' WARFARIN REVERSAL WITH FRESH FROZEN PLASMA TO REDUCE THE INR: A NOVEL SURVEY METHODOLOGYPetrozzino, J. / Hoesche, J. / Jones, C. et al. | 2011
-
PMD2 A META-ANALYSIS OF BIOMARKERS AND DIAGNOSTIC IMAGING IN ALZHEIMER'S DISEASESullivan, S. D. / Bloudek, L. / Spackman, D. E. / Blankenburg, M. et al. | 2011
-
PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSYDuh, M. S. / Faught, E. / Guerin, A. / Sarda, S. P. / Samuelson, T. / Bunker, M. T. / Olin, B. D. / Jackson, S. D. / Helmers, S. L. et al. | 2011
-
PMD9 ESTIMATION OF QUALITY-ADJUSTED LIFE EXPECTANCY AND LOSS OF QUALITY-ADJUSTED LIFE EXPECTANCY IN PATIENTS UNDER PROLONGED MECHANICAL VENTILATION: A POPULATION-BASED STUDY DURING 1998-2007 IN TAIWANHung, M. C. / Wang, J. D. et al. | 2011
-
PMD13 POST INGUINAL HERNIA REPAIR PAIN MANAGEMENT COSTS: A STUDY USING THE PREMIER PERSPECTIVE ™ DATABASE (PPD)Morseon, M. / Hashemi, L. et al. | 2011
-
PMD17 ANALYSIS OF COST DRIVERS IN STRUCTURED SMBG IN POORLY CONTROLLED, NON-INSULIN TREATED TYPE-2 DIABETES: RESULTS FROM THE STEP STUDYMyers, J. / Berndt, K. / Wegmann, N. / Rees, C. / Mast, O. / Wagner, R. et al. | 2011
-
PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIOChen, W. / Ellis, P. / Levin, L. / Krahn, M. et al. | 2011
-
PMD34 PREFERENCES FOR GENETIC TESTING TO ASSESS COLON-CANCER RISKSMohamed, A. F. / Johnson, F. R. / Knight, S. J. et al. | 2011
-
PMD30 IMPACT OF ACCESS TO A USUAL SOURCE OF CARE ON COMPLIANCE TO BREAST AND CERVICAL CANCER SCREENINGDatar, M. V. / Wu, W. K. et al. | 2011
-
PSU11 REDUCTION IN HEALTHCARE UTILIZATION AND EXPENDITURES IN PATIENTS TREATED WITH CATHETER ABLATION FOR ATRIAL FIBRILLATION (AF) IN THE UNITED STATESLadapo, J. A. / David, G. / Gunnarsson, C. / Hao, S. / White, S. / March, J. / Zang, M. / Reynolds, M. et al. | 2011
-
PSU21 THE REUSE OF SINGLE-USE SURGICAL DEVICES: EVALUATION OF THE ECONOMIC EVIDENCEEmmermann, A. / Schroeer, P. / Hamerslag, L. / Kusel, J. et al. | 2011
-
PSU19 NATIONWIDE UTILIZATION PATTERN OF WHOLE BRAIN RADIOTHERAPY AND STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASISJung, S. Y. / Hwang, J. S. / Choi, J. E. / Shin, S. Y. / Kim, J. H. / Hyun, M. K. / Kim, Y. E. / Bae, J. M. et al. | 2011
-
PDB7 DIET THERAPIES IN PATIENTS WITH TYPE-2 DIABETES: A MIXED-TREATMENT COMPARISON OF RANDOMIZED CONTROL TRIALSHarrington, A. R. / Malone, D. et al. | 2011
-
PDB10 ASSESSING THE ABILITY OF PATIENT REPORTED MEASURES TO DISCRIMINATE PROXIES FOR TREATMENT RESPONSECantrell, R. / Brenneman, S. / Kaplan, S. / Shen, W. / Brekke, L. / Billimek, J. / Paczkowski, R. / Haynes, V. / Greenfield, S. / Buesching, D. et al. | 2011
-
PDB17 ASSOCIATION OF YOUNGER AGE WITH POOR GLYCAEMIC AND CHOLESTEROL CONTROL IN ASIANS WITH TYPE-2 DIABETES IN SINGAPOREToh, M. P. / Wu, C. X. / Heng, B. H. et al. | 2011
-
PDB41 TREATMENT GAPS AMONG GROWTH HORMONE USERS IN A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATESFincher, C. / Kozma, C. / Meletiche, D. M. / Velez, F. et al. | 2011
-
PDB54 USE OF ELECTRONIC MEDICAL RECORDS FOR CLINICAL RESEARCH IN THE MANAGEMENT OF TYPE-2 DIABETESKamal, K. M. / Civitarese, L. et al. | 2011
-
PDB56 IMPACT OF PHARMACIST MANAGEMENT ON PATIENTS WITH DIABETES ENROLLED IN A RURAL FREE CLINICFranklin, M. / Sease, J. M. / Gerrald, K. R. et al. | 2011
-
PDB59 THE COMPLEXITY OF DRUG THERAPY AND SOCIO-ECONOMIC VARIANTS IN PATIENTS WITH DIABETESZhang, J. / Tao, J. et al. | 2011
-
PMH66 MULTIMORBIDITY AND DEPRESSION TREATMENTVyas, A. / Sambamoorthi, U. et al. | 2011
-
PIH11 COST ANALYSIS OF TOTAL PARENTERAL NUTRITION IN THE NEONATAL AND PEDIATRIC CARE IN BELGIAN HOSPITALSWalter, E. / Maton, P. / Dragosits, A. / Sondhi, S. / Turpin, R. / Liu, F. X. et al. | 2011
-
PIH17 COST-EFFECTIVENESS OF ABLE A FUNCTIONAL PROGRAM TO DECREASE MORTALITY IN COMMUNITY-DWELLING OLDER ADULTSJutkowitz, E. / Gitlin, L. / Pizzi, L. T. / Lee, E. H. / Dennis, M. et al. | 2011
-
PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAMIVUDINE FOR TREATMENT OF HIV INFECTED PATIENTS IN MEXICORely, K. / Salinas Escudero, G. / Alexandre, P. K. et al. | 2011
-
PIN8 EPIDEMIOLOGY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS AT A MIDWESTERN ACADEMIC HEALTH CARE CENTERJoshi, M. V. / Iwen, P. / Simonsen, K. / Tibbits, M. / Islam, M. et al. | 2011
-
PIN47 CRITICAL SUCCESS FACTORS FOR THE UPTAKE OF NOVEL VACCINES ONTO NATIONAL IMMUNUSATION PROGRAMMESOshinowo, B. / Grosvenor, A. / Ng-Haing, J. et al. | 2011
-
PIN48 TRENDS IN FUNDING OF SPECIALIST VACCINESScott, S. A. / Forster, L. et al. | 2011
-
PMS3 RISK FACTORS FOR NON-INITIATION OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARD) BY PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS (RA)Bonafede, M. / Johnson, B. H. / Fox, K. M. / Watson, C. / Gandra, S. R. et al. | 2011
-
PMS8 THE BUDGET IMPACT OF LOWER GPA ADHERENCE IN PATIENTS WITH CHRONIC NON-STEROIDAL AND COX-2 INHIBITOR USEBonafede, M. / Johnson, B. H. / Crawley, J. / Hellmund, R. et al. | 2011
-
PMS15 COMPARING HEALTH-RISK BURDEN, LOST PRODUCTIVITY, AND TOTAL HEALTH CARE COSTS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS AND TOP FIVE CHRONIC DISEASESNaim, A. / Pitts, J. / Chen, C. Y. / Wright, D. / Edington, D. et al. | 2011
-
PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSISBriones, B. / Bravo, M. G. / Garcí / a-Contreras, F. et al. | 2011
-
PMS32 ECONOMIC EVALUATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS WITH ANTI-TNF BIOLOGICAL THERAPIES IN COLOMBIAQuintana, G. / Restrepo, J. P. / Caceres, H. A. / Rueda, J. D. / Rosselli, D. et al. | 2011
-
PMS53 USE OF TNF-INHIBITORS IN THE UNITED STATES: UTILIZATION PATTERNS AND DOSE-ESCALATION FROM A REPRESENTATIVE UNITED STATES RA POPULATIONBedenbaugh, A. / Cyhaniuk, A. / Khanna, D. et al. | 2011
-
PMS67 FREQUENCY OF SELECT ANTI-TNF ADMINISTRATION OR RE-FILL IN PATIENTS WITH RHEUMATOID ARTHRITISSchmeichel-Mueller, C. / Bartels, A. / Silver, J. / Bolge, S. / Ingham, M. et al. | 2011
-
PRS2 INCREASED PREVALENCE OF OBSTRUCTIVE LUNG DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEAGreenberg-Dotan, S. / Reuveni, H. / Tal, A. / Oksenberg, A. / Cohen, A. / Shaya, F. T. / Tarasiuk, A. / Scharf, S. M. et al. | 2011
-
PRS4 LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASECheng, Y. / Raisch, D. W. / Roberts, M. et al. | 2011
-
PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENTGrimaldi-Bensouda, L. / Zureik, M. / Molimard, M. / Aubier, M. / Abenhaim, L. et al. | 2011
-
PRS36 HOSPITALIZATIONS, MEDICAL MANAGEMENT AND SWITCH THERAPY PATTERNS IN THE COPD MEDICARE POPULATIONEjzykowicz, F. / Hay, J. / Sarocco, P. / Karafilidis, J. / Walsh, J. et al. | 2011
-
PRS44 THE CHARIOT STUDY: NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISMArnold, R. J. / Groesser, K. / Baldwin, R. et al. | 2011
-
PRM33 TAKE TIME TO TRAIN: EVIDENCE TO SHOW THAT PATIENT TRAINING IN ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIALRoss, J. / Ross, E. / O'Gorman, H. J. / Peck, R. et al. | 2011
-
PRM30 RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D VALUATIONSBailey, H. / La Foucade, A. / Kind, P. et al. | 2011
-
PCN3 CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS WITH METASTATIC COLORECTAL CANCEROverbeek, J. A. / Zhao, Z. / van Herk-Sukel, M. P. / Barber, B. L. / Gao, S. / Herings, R. M. et al. | 2011
-
PCN22 ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTSRana, C. / Mann, K. / Wadhwa, A. et al. | 2011
-
PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASESBell, M. J. / Miller, J. D. / Namjoshi, M. / Russell, M. W. et al. | 2011
-
PCN52 WILLINGNESS TO PAY AND COST BENEFIT ANALYSIS OF DELIVERY METHODS FOR DECISION SUPPORT FOR RURAL CANCER PATIENTSWilson, L. S. / Loucks, A. / Franklin, L. / O'Donnell, S. / Moore, D. / Jupiter, C. / Kong, S. / Yeung, R. / Belkora, J. et al. | 2011
-
PCN57 ECONOMICS OF A MULTI-GENE ASSAY TO PREDICT RECURRENCE OF EARLY STAGE BREAST CANCER: EXPERIENCE OF A LARGE UNITED STATES INSURANCE PROGRAMHornberger, J. / Chien, R. / Kreb, K. / Hochheiser, L. I. et al. | 2011
-
PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMAPerrier, L. / Lefranc, A. / Quittet, P. / Moreau, P. / Siani, C. / Ghesquiè / res, H. / Jardin, F. / Favier, B. / Ifrah, N. et al. | 2011
-
PCN69 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT PATIENTS WITH ADVANCED PHASE CHRONIC MYELOGENOUS LEUKAEMIATaylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. et al. | 2011
-
PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPYPaulden, M. / Franek, J. / Pham, B. / Krahn, M. et al. | 2011
-
PCN90 PRO INSTRUMENTS USED TO MEASURE SYMPTOM IMPACTS OF FATIGUE AND PAIN IN PROSTATE CANCER DRUGS TRIALSPeeters, P. / Casamayor, M. / Moï / se, P. / Holmstrom, S. et al. | 2011
-
PCN113 LEARNING THE LESSONS OF ONCOLOGY HTA REVIEWS IN AUSTRALIA & THE UNITED KINGDOM – A CASE STUDY OF FIVE DRUGSLewis, S. / Dummett, H. et al. | 2011
-
PCN118 PREDICTING THE FUTURE IMPACT OF EMERGING TECHNOLOGIES ON HEPATOCELLULAR CARCINOMA (HCC): MEASURING STAKEHOLDERS PREFERENCES WITH BEST-WORST SCALINGGallego, G. / Bridges, J. F. / Flynn, T. / Blauvelt, B. M. et al. | 2011
-
PCN119 VALIDATION OF A NEW MEASURE OF PATIENT EMPOWERMENT IN ONCOLOGY: FIVE HEALTH EDUCATION IMPACT QUESTIONNAIRE (HEIQ) SCALESMaunsell, E. / Lauzier, S. / Brunet, J. / Campbell, S. / Elsworth, G. / Osborne, R. H. et al. | 2011
-
PCN130 RECORD-LINKAGE FOR PHARMACOEPIDEMIOLOGIC STUDIES IN CANCER PATIENTSvan Herk-Sukel, M. P. / Lemmens, V. / van de Poll, L. / Herings, R. M. / Coebergh, J. W. et al. | 2011
-
PGI11 THE ECONOMIC AND QUALITY OF LIFE BURDEN OF ILLNESS IN CHRONIC CONSTIPATION (CC) AND IRRITABLE BOWEL SYNDROME (IBS): A SYSTEMATIC REVIEWYee, K. / Nellesen, D. / Chawla, A. / Carson, R. / Lewis, B. et al. | 2011
-
PGI22 CONCORDANCE AMONG MULTIPLE HEALTH OUTCOMES MEASURES IN RESPONSIVENESS TO MULTI-MATRIX MESALAMINE MAINTENANCE TREATMENT FOR PATIENTS WITH QUIESCENT ULCERATIVE COLITISYen, L. / Yarlas, A. / Hodgkins, P. et al. | 2011
-
PMH39 COST-EFFECTIVENESS OF ANTIDEPRESSANT THERAPIES IN KOREAShin, S. / Jung, S. Y. / Song, H. / Park, J. / Ahn, J. et al. | 2011
-
PMH23 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH AND WITHOUT MEDICATION FOR OPIOID DEPENDENCYBaser, O. / Wang, L. / Xie, L. et al. | 2011
-
PMH30 INDIRECT COSTS (IC) OF ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 FROM THE MEDICAL EXPENDITURES PANEL SURVEY (MEPS)Kavati, A. / Rappaport, H. et al. | 2011
-
PMH38 ECONOMIC IMPLICATIONS OF THE EFFECT OF LURASIDONE VERSUS OTHER SELECTED ATYPICAL ANTIPSYCHOTICS ON CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH SCHIZOPHRENIAGuo, S. / Hernandez, L. / Green, J. / Sarocco, P. et al. | 2011